|








| |

Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in
Patients with Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
Circulation. 2003;108:3084-3091
Domenico
Corrado, MD, PhD; Loira Leoni, MD; Mark S. Link, MD; Paolo Della Bella, MD;
Fiorenzo Gaita, MD; Antonio Curnis, MD; Jorge Uriarte Salerno, MD; Diran
Igidbashian, MD; Antonio Raviele, MD; Marcello Disertori, MD; Gabriele
Zanotto, MD; Roberto Verlato, MD; Giuseppe Vergara, MD; Pietro Delise, MD;
Pietro Turrini, MD, PhD; Cristina Basso, MD, PhD; Franco Naccarella, MD;
Francesco Maddalena, MD; N.A. Mark Estes, III, MD; Gianfranco Buja, MD;
Gaetano Thiene, MD
In patients with ARVC/D, ICD therapy
provided life-saving protection by effectively terminating life-threatening
ventricular arrhythmias. Patients who were prone to ventricular
fibrillation/flutter could be identified on the basis of clinical presentation,
irrespective of programmed ventricular stimulation outcome.
Determinants of Sudden Cardiac Death in Individuals with the
Electrocardiographic Pattern of Brugada Syndrome and No Previous Cardiac Arrest
Circulation. 2003;108:3092-3096
Josep Brugada, MD, PhD; Ramon Brugada,
MD; Pedro Brugada, MD, PhD
Multivariate
analysis identified the inducibility of a sustained ventricular arrhythmia
(P<0.0001) and a history of syncope (P<0.01) as predictors of events.
Logistic regression analysis showed that a patient with a spontaneously abnormal
ECG, a previous history of syncope, and inducible sustained ventricular
arrhythmias had a probability of 27.2% of suffering an event during follow-up.
Use of automated external defibrillator by first responders in out of hospital
cardiac arrest: prospective controlled trial
BMJ 2003;327:1312
Anouk P van Alem, junior scientist, Rob H Vrenken, medical director,
municipal health service, Rien de Vos, clinical epidemiologist, Jan G P
Tijssen, clinical epidemiologist, Rudolph W Koster, lecturer in cardiology
Use of automated external defibrillators
by first responders did not significantly increase survival to discharge from
hospital, although it did improve return of spontaneous circulation and
admission to hospital. Improved dispatch procedures should increase the
success of programmes of first responders using external defibrillators.
Congenital Short QT Syndrome and Implantable Cardioverter Defibrillator
Treatment: Inherent Risk for Inappropriate Shock Delivery
Journal of Cardiovascular Electrophysiology Volume 14
Issue 12 Page 1273 - December 2003
RAINER SCHIMPF, M.D., CHRISTIAN WOLPERT, M.D., FRANCESCA BIANCHI, M.D.,
CARLA GIUSTETTO, M.D., FIORENZO GAITA, M.D., URS BAUERSFELD, M.D., and MARTIN
BORGGREFE, M.D.
The congenital short QT syndrome
constitutes a new clinical entity with an increased risk for sudden cardiac
death. Currently, ICD treatment is the only therapeutic option.
Implantable Cardioverter Defibrillator Events in Patients with Asymptomatic
Nonsustained Ventricular Tachycardia: Is Device Implantation Justified?
Pacing and Clinical Electrophysiology Volume 26 Issue 12
Page 2289 - December 2003
ANDREA M. RUSSO, HEMAL NAYAK, RALPH VERDINO, JAMIE SPRINGMAN, EDWARD
GERSTENFELD, HENRY HSIA, and FRANCIS E. MARCHLINSKI
Patients with coronary disease and
asymptomatic NSVT commonly receive appropriate defibrillator therapy. These results support the need for ICD
implantation for primary prevention, with attention to careful
programming of the detection rate to prevent inappropriate therapy.
Usefulness of ST-segment elevation in lead aVR during tachycardia for
determining the mechanism of narrow QRS complex tachycardia
Am J Cardiol 15 December 2003,
Volume 92, Issue 12 Pages 1424-1428
Yi-Lwun Ho, Lian-Yu Lin, Jiunn-Lee Lin, Ming-Fong Chen, Wen-Jone Chen
and Yuan-Teh Lee
aVR ST-segment elevation during narrow
QRS complex tachycardia favors the atrioventricular reentry through an accessory
pathway as the mechanism of the tachycardia.
Total Atrioventricular Nodal Ablation Increases Atrial Fibrillation Burden in
Patients with Paroxysmal Atrial Fibrillation Despite Continuation of
Antiarrhythmic Drug Therapy
Journal of Cardiovascular Electrophysiology Volume 14
Issue 12 Page 1296 - December 2003
RIK WILLEMS, M.D., D. GEORGE WYSE, M.D., Ph.D., and ANNE M. GILLIS,
M.D., for the Atrial Pacing Periablation for Paroxysmal Atrial Fibrillation
(PA3) Study Investigators
TAVN ablation increases AF burden and
facilitates the development of persistent AF in patients with paroxysmal AF
despite the continuation of antiarrhythmic drugs. Loss of AV and/or
interventricular synchrony may lead to altered cardiac hemodynamics resulting in
atrial stretch and increasing AF burden.
Left Atrial Radiofrequency Ablation During Cardiac Surgery in Patients with
Atrial Fibrillation
Journal of Cardiovascular Electrophysiology Volume 14
Issue 12 Page 1289 - December 2003
ROBERTO MANTOVAN, M.D., ANTONIO RAVIELE, M.D., GIANFRANCO BUJA, M.D.,
EMANUELE BERTAGLIA, M.D., FRANCESCO CESARI, M.D., ALESSANDRA PEDROCCO, M.D.,
CLAUDIO ZUSSA, M.D., GINO GEROSA, M.D., CARLO VALFRÈ, M.D., and PAOLO STRITONI,
M.D., on behalf of the North-eastern Italian Study on Radiofrequency Surgical
Treatment of Atrial Fibrillation Investigators
Endocardial RF
left atrial compartmentalization during cardiac surgery is effective in
restoring sinus rhythm in many patients. This technique is easy to perform and
reproducible. Rare RF ablation-related complications can occur. During
follow-up, sinus rhythm persistence is good, and biatrial contraction is
preserved in most patients.
Evaluation of the Appropriateness of Pacemaker Mode Selection in Bradycardia
Pacing: How Closely are the ACC/AHA Guidelines Followed?
Pacing and Clinical Electrophysiology Volume 26 Issue 12
Page 2301 - December 2003
MARLEEN E. IRWIN, KEVIN R. BAINEY, and MANOHARA P. J. SENARATNE
(1) elderly denied a dual chamber system
with no clinical explanation and (2)
selection of rate-modulated devices
without any indication of chronotropic incompetence.
Optimal Pacing for Symptomatic AV Block: A Comparison of VDD and DDD Pacing
Pacing and Clinical Electrophysiology Volume 26 Issue 12
Page 2230 - December 2003
MAX HUANG, ANDREW D. KRAHN, RAYMOND YEE, GEORGE J. KLEIN, and ALLAN C.
SKANES
The lower cost, high
reliability, and abbreviated implantation time suggest that VDD pacing is a
viable alternative to DDD pacing in patients with high-degree AV block and
normal sinus node function.
Long-term effectiveness of cardiac resynchronization therapy in patients with
refractory heart failure and “narrow” QRS
J Am Coll Cardiol 17 December
2003, Volume 42, Issue 12 Pages 2117-2124
Augusto
Achilli, Massimo Sassara, Sabina Ficili, Daniele Pontillo, Paola Achilli,
Claudio Alessi, Stefano De Spirito, Roberto Guerra, Nicolino Patruno and
Francesco Serra
Cardiac
resynchronization therapy determined clinical and functional benefit that was
similar in patients with wide or “narrow” QRS. Cardiac resynchronization therapy may be
helpful in patients with echocardiographic evidence of interventricular and
intraventricular asynchrony and incomplete left bundle branch block.
Noninvasive Arrhythmia Risk Stratification in Idiopathic Dilated Cardiomyopathy:
Results of the Marburg Cardiomyopathy Study
Circulation. 2003;108:2883
Wolfram
Grimm, MD; Michael Christ, MD; Jennifer Bach, MD; Hans-Helge Müller, PhD;
Bernhard Maisch, MD
Reduced LV ejection fraction and lack of
ß-blocker use are important arrhythmia risk predictors in IDC, whereas
signal-averaged ECG, baroreflex sensitivity, heart rate variability, and T-wave
alternans do not seem to be helpful for arrhythmia risk stratification.
The optimal intensity of vitamin k antagonists in patients with mechanical heart
valves: A meta-analysis
J Am Coll Cardiol 17 December
2003, Volume 42, Issue 12 Pages 2042-2048
Roel
Vink, Roderik A. Kraaijenhagen, Barbara A. Hutten, Renee B. A. van den Brink,
Bas A. de Mol, Harry R. Büller and Marcel Levi
This
meta-analysis shows that both aortic and
mitral valves will benefit from a treatment strategy with a target INR higher
than 3.0.
Clinical efficacy of cardiac resynchronization therapy using left ventricular
pacing in heart failure patients stratified by severity of ventricular
conduction delay
J Am Coll Cardiol 17 December
2003, Volume 42, Issue 12 Pages 2109-2116
Angelo Auricchio, Christoph Stellbrink, Christian Butter, Stefan Sack,
Jürgen Vogt, Anand Ramdat Misier, Dirk Böcker, Michael Block, Johannes H.
Kirkels, Pacing Therapies in Congestive Heart Failure (PATH-CHF) II Study
Group Andrew Kramer, Etienne Huvelle and Guidant Heart Failure Research Group
Left ventricular pacing significantly
improves exercise tolerance and quality of life in patients with chronic HF, LV
systolic dysfunction, and a QRS interval over 150 ms.
Routine vitamin supplementation to prevent cardiovascular disease: a summary of
the evidence for the U.S. preventive services task force
Ann Intern Med 2003;139:51–5
C.D.
Morris and S. Carson
The US Preventive Services Task Force (USPSTF) concluded the evidence is insufficient to
recommend for or against use of supplements of vitamin A, C or E; multivitamins
with folic acid or antioxidant combinations for the prevention of cancer or CV
disease. The USPSTF recommends against use of beta carotene supplements
alone or in combination for the prevention of either cancer or CVD.
Inflammation as
a Risk Factor for Atrial Fibrillation
Circulation. 2003;108:3006
Ronnier J. Aviles, MD; David O. Martin, MD, MPH; Carolyn Apperson-Hansen,
MS; Penny L. Houghtaling, MS; Pentti Rautaharju, MD; Richard A. Kronmal, PhD;
Russell P. Tracy, PhD; David R. Van Wagoner, PhD; Bruce M. Psaty, MD, PhD;
Michael S. Lauer, MD; Mina K. Chung, MD
CRP is not only associated with the
presence of AF but may also predict patients at increased risk for future
development of AF.
Successful Catheter Ablation of Electrical Storm after Myocardial Infarction
Circulation. 2003;108:3011
Dietmar Bänsch, MD; Feifan Oyang, MD; Matthias Antz, MD; Thomas Arentz,
MD; Reinhold Weber, MD; Jesus E. Val-Mejias, MD; Sabine Ernst, MD; Karl-Heinz
Kuck, MD
Incessant ventricular
tachyarrhythmias after MI may be triggered by VPBs. RF ablation of the
triggering VPBs is feasible and can prevent drug-resistant electrical storm,
even after acute MI.
Long QT syndrome patients may faint due to
neurocardiogenic syncope
EUROPACE, October 2003 | Volume 5, Issue 4 | Pages
367-370
E. Toft,J. Aarøe,B.T. Jensen,M. Christiansen,L. Fog,P.E.B. Thomsen,J.K.
Kanters
Syncope in LQTS
can be of neurocardiogenic origin and is not necessarily due to TdP.
Use of enalapril to facilitate sinus rhythm
maintenance after external cardioversion of long-standing persistent atrial
fibrillation
EUROPEAN HEART JOURNAL December 2003 | Volume 24, Issue
23 | Pages 2090-2098
Kwo-Chang Ueng,Tsung-Po Tsai,Wen-Chung Yu,Chin-Feng Tsai,Ming-Cheng
Lin,Kuei-Chuan Chan,Chung-Yin Chen,Der-Jinn Wu,Chung-Sheng Lin,Shih-Ann Chen
The addition of
enalapril to amiodarone decreased the rate of immediate and subacute arrhythmia
recurrences and facilitated subsequent long-term maintenance of sinus rhythm
after cardioversion of persistent AF.
Diazepam or midazolam for external DC cardioversion
(The DORM Study)
EUROPACE October 2003 | Volume 5, Issue 4 | Pages
391-395
A.R.J. Mitchell,S. Chalil,L. Boodhoo,G. Bordoli,N. Patel,N. Sulke
Physician-led
cardioversion of atrial arrhythmias using intravenous sedation is effective and
well tolerated. Sedation with diazepam was associated with fewer minor adverse
events and a quicker recovery time than midazolam.
Chronic periodontitis, a significant relationship
with acute myocardial infarction
EUROPEAN HEART JOURNAL December 2003 | Volume 24, Issue
23 | Pages 2108-2115
G. Rutger Persson,Ola Ohlsson,Thomas Pettersson,Stefan Renvert
Patients who at routine
dental visits demonstrate evidence of bone loss around several teeth can
predictably be identified as being at risk for future AMI.
Walk test at increased levels of heart rate in
patients with dual-chamber pacemaker and with normal or depressed left
ventricular function
EUROPEAN HEART JOURNAL December 2003 | Volume 24, Issue
23 | Pages 2123-2132
Adele
Ferro,Carlo Duilio,Maurizio Santomauro,Alberto Cuocolo
Increasing heart
rate in presence of ventricular asynchrony induced by dual-chamber pacing has
negative effect on cardiac contractility and does not improve CO at rest or
during physical activity in patients with depressed LV function as occurs in
those with normal function.
Comparison of effectiveness of implantable
cardioverter defibrillator in patients with idiopathic dilated cardiomyopathy
versus those with proved coronary heart disease
Am J Cardiol
15 November 2003, Volume 92, Issue 10
Pages 1227-1230
Alejandro Cuesta, Lluís Mont, Ulises Rogel, Mariana Valentino, Mariona Matas
and Josep Brugada
There were no
differences in the type and probability of recurrences at follow-up.
Optimal duration of monitoring in patients with
unexplained syncope
Am J Cardiol
15 November 2003, Volume 92, Issue 10 Pages 1231-1233
Manish D. Assar, Andrew D. Krahn, George J. Klein, Raymond Yee and Allan
C. Skanes
There is a low risk of syncope after 1 year of monitoring without an event.
Water Ingestion as
Prophylaxis Against Syncope
Circulation. 2003;108:2660
Chih-Cherng Lu, MD, MS; André Diedrich, MD, PhD; Che-Se Tung, MD, PhD; Sachin Y.
Paranjape, BS; Paul A. Harris, PhD; Daniel W. Byrne, MS; Jens Jordan, MD; David
Robertson, MD
Water enhances tolerance of upright
posture. The effect of water is
mediated by increased peripheral vascular resistance.
Prevention of atrial fibrillation recurrence by statin therapy in patients with
lone atrial fibrillation after successful cardioversion
Am J Cardiol 1 December 2003,
Volume 92, Issue 11 Pages 1343-1345
Chung-Wah
Siu a, Chu-Pak Lau a and Hung-Fat Tse a
The use of statins was associated with a
significant decrease in the risk of arrhythmia recurrence after successful
cardioversion of AF.
A new oral therapy for long QT syndrome: Long-term oral potassium improves
repolarization in patients with HERG mutations
J Am Coll Cardiol 19 November
2003, Volume 42, Issue 10 Pages 1777-1782
Susan P.
Etheridge, Steven J. Compton, Martin Tristani-Firouzi and Jay W. Mason
Long-term oral potassium
administration increases serum K+ in patients with LQT2. This can be achieved
safely and results in improvement in repolarization.
Depressive symptoms and the risk of sudden cardiac death among the elderly
EUROPEAN HEART JOURNAL November
2003 | Volume 24, Issue 22 | Pages 2021-2026
H.
Luukinen,P. Laippala,H. V. Huikuri
Depressive symptoms increase the risk of
SCD, but not that of non-SCD and non-fatal MI among the elderly subjects.
QT-interval prolongation in right precordial leads: an additional
electrocardiographic hallmark of Brugada syndrome
J Am Coll Cardiol November
2003, Volume 42, Issue 9 Pages 1632-1637
Maria
Vittoria Pitzalis, Matteo Anaclerio, Massimo Iacoviello, Cinzia Forleo, Pietro
Guida, Rossella Troccoli, Francesco Massari, Filippo Mastropasqua, Sandro
Sorrentino, Andrea Manghisi and Paolo Rizzon
In accordance with the
electrophysiological background, the typical ECG pattern of Brugada syndrome is
also characterized by a considerable prolongation of the QT interval in right
precordial leads.
Randomized Controlled Trial of Fixed Rate Versus Rate Responsive Pacing After
Radiofrequency Atrioventricular Junction Ablation: Quality of Life, Ventricular
Refractoriness, and Paced QT Dispersion
Journal of Cardiovascular Electrophysiology Volume 14
Issue 11 Page 1163 - November 2003
HENRY J. DUFF, M.D., SATISH R. RAJ, M.D., DEREK V. EXNER, M.D., M.P.H.,
ROBERT S. SHELDON, M.D., Ph.D., DAN ROACH, Ph.D., L. BRENT MITCHELL, M.D., D.
GEORGE WYSE, M.D., Ph.D., MARGARET MORCK, R.N., and ANNE M. GILLIS, M.D.
Rate responsive pacing results in
electrical remodeling of the ventricle following AV junction ablation, but
exercise capacity was similar in groups with RR-ON or RR-OFF.
Right Ventricular Outflow Versus Apical Pacing in Pacemaker Patients with
Congestive Heart Failure and Atrial Fibrillation
Journal of Cardiovascular Electrophysiology Volume 14
Issue 11 Page 1180 - November 2003
BRUCE S. STAMBLER, M.D., KENNETH A. ELLENBOGEN, M.D., XIAOZHENG ZHANG,
M.D., THOMAS R. PORTER, M.D., FENG XIE, M.D., RAJESH MALIK, M.D., ROY SMALL,
M.D., MARTIN BURKE, D.O., ANDREW KAPLAN, M.D., LAWRENCE NAIR, M.D., MICHAEL
BELZ, M.D., CHARLES FUENZALIDA, M.D., MICHAEL GOLD, M.D., CHARLES LOVE, M.D.,
ARJUN SHARMA, M.D., RUSSELL SILVERMAN, M.D., FELIX SOGADE, M.D., BRUCE VAN
NATTA, M.D., and BRUCE L. WILKOFF, M.D., for the ROVA Investigators
In patients with
CHF, LV dysfunction, and chronic AF,
RVOT and dual-site RV pacing shorten QRS duration but after 3 months do not
consistently improve QOL or other clinical outcomes compared with RVA
pacing.
A Randomized Study of Prophylactic Catheter Ablation in Asymptomatic Patients
with the Wolff–Parkinson–White Syndrome
New Engl J Med Volume
349:1803-1811 November 6, 2003 Number 19
Carlo
Pappone, M.D., Ph.D., Vincenzo Santinelli, M.D., Francesco Manguso, M.D.,
Ph.D., Giuseppe Augello, M.D., Ornella Santinelli, M.D., Gabriele Vicedomini,
M.D., Simone Gulletta, M.D., Patrizio Mazzone, M.D., Valter Tortoriello, M.D.,
Alessia Pappone, M.D., Cosimo Dicandia, M.D., and Salvatore Rosanio, M.D.,
Ph.D.
Prophylactic accessory-pathway ablation
markedly reduces the frequency of arrhythmic events in asymptomatic patients
with the Wolff–Parkinson–White syndrome who are at high risk for such events.
Catheter Ablation for Paroxysmal Atrial Fibrillation Segmental Pulmonary Vein
Ostial Ablation Versus Left Atrial Ablation
Circulation. 2003;108:2355
Hakan
Oral, MD; Christoph Scharf, MD; Aman Chugh, MD; Burr Hall, MD; Peter Cheung,
MD; Eric Good, DO; Srikar Veerareddy, MD; Frank Pelosi, Jr, MD; Fred Morady,
MD
In patients
undergoing catheter ablation for PAF,
LACA to encircle the PVs is more effective than SOCA.
Report of erectile dysfunction after therapy with beta-blockers is related to
patient knowledge of side effects and is reversed by placebo
EUROPEAN HEART JOURNAL November
2003 | Volume 24, Issue 21 | Pages 1928-1932
Antonello Silvestri,Pasquale Galetta,Elena Cerquetani,Giuseppe Marazzi,Roberto
Patrizi,Massimo Fini,Giuseppe M.C. Rosano
The knowledge and prejudice about side
effects of beta-blockers can produce anxiety, that may cause erectile function.
The Influence of High Versus Normal Impedance Ventricular Leads on Pacemaker
Generator Longevity
Pacing and Clinical
Electrophysiology Volume 26 Issue 11 Page 2116 - November 2003
THOMAS
BERGER, FRANZ X. ROITHINGER, HERWIG ANTRETTER*, HERBERT HANGLER*, OTMAR
PACHINGER, and FLORIAN HINTRINGER
Implantation of a high
impedance lead for ventricular pacing results in a clinically relevant extension
of generator longevity.
Death in patients with permanent pacemakers for sick sinus syndrome
Am Heart J November 2003 •
Volume 146 • Number 5
Greg
Flaker, MD, FACC Arnold Greenspon, MD, FACC Barbara Tardiff, MD Eleanor Schron,
MS, RN Lee Goldman, MD, FACC Anne Hellkamp, MS Kerry Lee, PhD Gervasio Lamas,
MD, FACC Mode Selection Trial (MOST) Investigators
After a median follow-up of 33 months,
404 (20%) patients died, including 198 (49%) of noncardiac causes. Patients treated with permanent
pacemakers for sinus node dysfunction are elderly and have a substantial
mortality rate, with more than half the classifiable deaths being noncardiac.
Comparison of Standard Cardiopulmonary Resuscitation Versus the Combination of
Active Compression-Decompression Cardiopulmonary Resuscitation and an
Inspiratory Impedance Threshold Device for Out-of-Hospital Cardiac Arrest
Circulation. 2003;108:2201
Benno B.
Wolcke, MD; Dietmar K. Mauer, MD, PhD; Mark F. Schoefmann, MD; Heinke
Teichmann, MD; Terry A. Provo, BA; Karl H. Lindner, MD, PhD; Wolfgang F. Dick,
MD, PhD; Dorothee Aeppli, PhD; Keith G. Lurie, MD
Compared with
S-CPR, ACD+ITD CPR significantly improved short-term survival rates for patients
with out-of-hospital cardiac arrest. Additional studies are needed to evaluate
potential long-term benefits of ACD+ITD CPR.
Orthostatic headaches without CSF leak in postural tachycardia syndrome
NEUROLOGY 2003;61:980-982
Bahram Mokri, MD and Phillip A. Low, MD
Orthostatic headaches are not always caused by CSF
leak or supine intracranial hypotension. Occasionally they may be the major
clinical manifestation of postural tachycardia syndrome or orthostatic
intolerance.
Unexplained syncope in patients with structural heart disease and no documented
ventricular arrhythmias: value of electrophysiologically guided implantable
cardioverter defibrillator therapy
Europace Volume 5, Issue 3 ,
July 2003, Pages 305-312
T. Pezawas, G. Stix, J. Kastner,
M. Wolzt, C. Mayer, D. Moertl and H. Schmidinger
Syncope per se does
not necessarily herald a bad prognosis. PVS identifies high-risk patients.
Induction of ventricular fibrillation with double or triple extrastimuli is of
limited value. Patients with poor left ventricular function and bad clinical
condition benefit most from an ICD.
Long-Term Complication Rates in Ventricular, Single Lead VDD, and Dual Chamber
Pacing
Pacing and Clinical
Electrophysiology Volume 26 Issue 10 Page 1961 - October 2003
UWE K.H. WIEGAND,
FRANK BODE, HENDRIK BONNEMEIER, FRANK EBERHARD, MONIKA SCHLEI, and WERNER PETERS
Operation time and complication rates of physiological
pacing are reduced by VDD pacemaker implantation.
Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical
therapy
J Am Coll Cardiol 2003, Volume 42, Issue 7 Pages 1161-1170
Robert A. Henderson, Stuart J.
Pocock, Tim C. Clayton, Rosemary Knight, Keith A. A. Fox, Desmond G. Julian,
Douglas A. Chamberlain and Second Randomized Intervention Treatment of Angina
(RITA-2) Trial Participants
An initial
strategy of PTCA did not influence the risk of death or MI, but it improved
angina and exercise tolerance. Patients considered suitable for PTCA or medical
therapy can be safely managed with continued medical therapy, but percutaneous
intervention is appropriate if symptoms are not controlled.
Predictors and Clinical Impact of Atrial Fibrillation After Pacemaker
Implantation in Elderly Patients Treated with Dual Chamber Versus Ventricular
Pacing
Pacing and Clinical
Electrophysiology Volume 26 Issue 10 Page 2000 - October 2003
BRUCE S. STAMBLER, KENNETH A.
ELLENBOGEN, E. JOHN ORAV, ELENA B. SGARBOSSA, N. A. MARK ESTES III, CARLOS RIZO-PATRON,
JAMES B. KIRCHHOFFER, TOM A. HADJIS, LEE GOLDMAN, and GERVASIO A. LAMAS, for the
Pacemaker Selection in the Elderly (PASE) Trial Investigators
DDDR
pacing mode protected against the development of AF.
Chronic Experiences with a Single Lead Dual Chamber Implantable Cardioverter
Defibrillator System
Pacing and Clinical
Electrophysiology Volume 26 Issue 10 Page 1937 - October 2003
MICHAEL NIEHAUS, MARCOS DE
SOUSA, GUNNAR KLEIN, THOMAS KORTE, DIETRICH PFEIFFER, THORSTEN WALLES,
KONSTANTINOS RAYMONDOS, and JUERGEN TEBBENJOHANNS
The first experiences with the new VDD-ICD system show an increase of the
specificity to detect ventricular tachycardias to a level comparable to dual
chamber ICDs with two leads.
Coincidence of idiopathic ventricular outflow tract tachycardia and
atrioventricular nodal reentrant tachycardia
Europace Volume 5, Issue 3 ,
July 2003, Pages 215-220
J. Kautzner, , R. ihák, V.
Vanura and J. Byteník
Coincidence of idiopathic
outflow tract VT and AVNRT was found in 15% of cases of clinically documented
idiopathic VT.
Clinical and electrophysiological characteristics in patients with
atrioventricular reentrant and atrioventricular nodal reentrant tachycardia
Europace Volume 5, Issue 3 ,
July 2003, Pages 225-229
N. Bottoni, C.
Tomasi, P. Donateo, G. Lolli, N. Muià, F. Croci, D. Oddone, C. Menozzi and M.
Brignole
Patients with AVRT
have a lower mean age at arrhythmia symptom onset compared with those with AVNRT
and have fewer associated cardiac abnormalities. Clinical presentation is quite
similar as well as their outcome after ablation.
Comparison of the haemodynamic effects of
right ventricular outflow-tract pacing with right ventricular apex pacing: A
quantitative review
Europace Volume 5, Issue 3 ,
July 2003, Pages 275-278
C. C. de Cock, M. C. Giudici and
J. W. Twisk
Right ventricular outflow-tract
pacing may offer a modest but significant benefit over right ventricular apex
pacing in patients selected for pacemaker implantation on the basis of
symptomatic bradyarrhythmias.
Effects of Eplerenone, Enalapril, and Eplerenone/Enalapril in Patients With
Essential Hypertension and Left Ventricular
Hypertrophy The 4E–Left Ventricular Hypertrophy
Study
Circulation. 2003;108:1831
Bertram Pitt, MD; Nathaniel
Reichek, MD; Roland Willenbrock, MD; Faiez Zannad, MD; Robert A. Phillips, MD;
Barbara Roniker, MD; Jay Kleiman, MD; Scott Krause, BSN; Daniel Burns, BS;
Gordon H. Williams, MD
Eplerenone was as
effective as enalapril in LVH regression and blood pressure control. The
combination of eplerenone and enalapril was more effective in reducing
LV mass and systolic blood pressure than
eplerenone alone.
Prolonged Atrial Action Potential Durations and Polymorphic Atrial
Tachyarrhythmias in Patients with Long QT Syndrome
Journal of Cardiovascular
Electrophysiology Volume 14 Issue 10 Page 1027 - October 2003
PAULUS
KIRCHHOF, M.D., LARS ECKARDT, M.D., MICHAEL R. FRANZ, M.D., Ph.D.*, GEROLD
MÖNNIG, M.D., PETER LOH, M.D., HORST WEDEKIND, M.D., ERIC SCHULZE-BAHR, M.D.,
GÜNTER BREITHARDT, M.D., and WILHELM HAVERKAMP, M.D.
PolyAT appears to be
a specific arrhythmia of LQTS reminiscent of an atrial form of "torsades de
pointes."
QRS duration and prediction of mortality in patients undergoing risk
stratification for ventricular arrhythmias
Am J Cardiol 1 October 2003,
Volume 92, Issue 7 Pages 798-803
Vidyasagar Kalahasti a, Vijay Nambi a, David O. Martin a, Cathy T. Lam b,
David Yamada c, Bruce L. Wilkoff a, Mark J. Niebauer d, Fredrick J. Jaeger a,
Patrick J. Tchou a and Mina K. Chung a
Prolonged QRS duration is a strong
independent marker of long-term mortality in patients who undergo risk
stratification for ventricular arrhythmias.
Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an
independent marker of sudden death risk in young patients
JACC 3 September 2003, Volume
42, Issue 5 Pages 873-879
Lorenzo
Monserrat, Perry M. Elliott, Juan R. Gimeno, Sanjay Sharma, Manuel Penas-Lado
and William J. McKenna
Non-sustained ventricular tachycardia is
associated with a substantial increase in sudden death risk in young patients
with HCM.
Sulfonylureas attenuate electrocardiographic ST-segment elevation during an
acute myocardial infarction in diabetics
JACC 17 September 2003, Volume
42, Issue 6 Pages 1017-1021
Jose F.
Huizar, Luis A. Gonzalez, James Alderman and Harton S. Smith
Sulfonylurea therapy appears to
attenuate the magnitude of ST-segment elevation during an AMI, resulting in
failure to meet criteria for thrombolytic therapy.
Significant gender-related differences in radiofrequency catheter ablation
therapy
JACC 17 September 2003, Volume
42, Issue 6 Pages 1103-1107
Nikolaos
Dagres, Jonathan R. Clague, Günter Breithardt and Martin Borggrefe
Women are referred for ablation later
than are men, after a longer duration of symptoms, and after having been given
more antiarrhythmic drugs.
Comparison of the haemodynamic effects of right ventricular outflow-tract pacing
with right ventricular apex pacing: A quantitative review
Europace Volume 5, Issue 3 ,
July 2003, Pages 275-278
C. C. de
Cock, , 1, M. C. Giudici2 and J. W. Twisk3
Right ventricular outflow-tract pacing
may offer a modest but significant benefit over right ventricular apex pacing
in patients selected for pacemaker implantation on the basis of symptomatic
bradyarrhythmias.
QRS duration: a simple marker for predicting cardiac mortality in ICD patients
with heart failure
Heart 2003;89:1157-1162
L
Bode-Schnurbus1, D Böcker1, M Block1, R Gradaus1, A Heinecke2, G Breithardt1
and M Borggrefe3
Within subgroups at
highest risk of cardiac death, QRS duration—a simple non-invasive index—predicts
outcome in ICD recipients in the presence of heart failure.
Ventricular Flutter Induced During Electrophysiologic Studies in Patients with
Old Myocardial Infarction: Clinical and Electrophysiologic Predictors, and
Prognostic Significance
Journal of Cardiovascular Electrophysiology Volume 14
Issue 9 Page 913 - September 2003
SAMI VISKIN, M.D., MAYA ISH-SHALOM, M.D., EDWARD KOIFMAN, M.D., URI
ROZOVSKI, M.D., DAVID ZELTSER, M.D., AHARON GLICK, M.D., ARIEL FINKELSTEIN,
M.D., AMIR HALKIN, M.D., ROMAN FISH, M.D., and BERNARD BELHASSEN, M.D.
The prognostic
value of inducible ventricular flutter is comparable to that of SMVT.
Are Electrophysiological Studies Needed Prior to Defibrillator Implantation?
Pacing and Clinical
Electrophysiology Volume 26 Issue 8 Page 1715 - August 2003
RUEDIGER
BECKER, MICHAIL MELKUMOV, JULIA C. SENGES-BECKER, FREDERIK VOSS, ALEXANDER
BAUER, JOCHEN MICHAELSEN, SLAWOMIR WERETKA, FERAYDOON NIROOMAND, HUGO A. KATUS,
and WOLFGANG SCHOELS
Based on these retrospective data,
routine electrophysiological study prior to ICD implantation seems to be
advisable.
Analysis of Implantable Cardioverter Defibrillator Therapy in the
Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial
Journal of Cardiovascular Electrophysiology Volume 14
Issue 9 Page 940 - September 2003
RICHARD C. KLEIN, M.D., MERRITT H. RAITT, M.D., BRUCE L. WILKOFF, M.D.,
KAREN J. BECKMAN, M.D., JAMES COROMILAS, M.D., D. GEORGE WYSE, M.D., PETER L.
FRIEDMAN, M.D., JAMES B. MARTINS, M.D., ANDREW E. EPSTEIN, M.D., ALFRED P.
HALLSTROM, Ph.D., ROBERT B. LEDINGHAM, M.S., KAREN M. BELCO, R.N., H. LEON
GREENE, M.D., and The Avid Investigators
An
appropriate shock was delivered in 53%. The first arrhythmia treated in
follow-up was diagnosed as VT (63%), VF (13%), supraventricular tachycardia (18%), unknown arrhythmia (3%), or due to ICD malfunction or inappropriate
sensing (3%). Acceleration of an
arrhythmia by the ICD occurred in 8%.
Mitral Valve Surgery Can Now Routinely Be Performed Endoscopically
Circulation. 2003;108:II-48
Filip P.
Casselman, MD, PhD, FETCS; Sam Van Slycke, MD; Francis Wellens, MD, FETCS;
Raphael De Geest, MD; Ivan Degrieck, MD, FETCS; Frank Van Praet, MD, FETCS;
Yvette Vermeulen, MSc; Hugo Vanermen, MD, FETCS
Endoscopic mitral valve surgery can be
performed safely but definitely requires a learning curve. Good results and a
high patient satisfaction are guaranteed.
Percutaneous Pericardial Instrumentation for Endo-Epicardial Mapping of
Previously Failed Ablations
Circulation. 2003;108:1329
Robert
A. Schweikert, MD; Walid I. Saliba, MD; Gery Tomassoni, MD; Nassir F.
Marrouche, MD; Christopher R. Cole, MD; Thomas J. Dresing, MD; Patrick J.
Tchou, MD; Dianna Bash, RN; Salwa Beheiry, RN; Cathy Lam, MD; Logan
Kanagaratnam, MD; Andrea Natale, MD
Epicardial instrumentation
and ablation appeared feasible and safe and provided an alternative strategy for
the treatment of patients with a variety of arrhythmias.
Clinical and electrophysiological characteristics in patients with
atrioventricular reentrant and atrioventricular nodal reentrant tachycardia
Europace Volume 5, Issue 3 ,
July 2003, Pages 225-229
N.
Bottoni, , 1, C. Tomasi1, P. Donateo2, G. Lolli1, N. Muià1, F. Croci2, D.
Oddone2, C. Menozzi1 and M. Brignole2
Patients with AVRT have a lower mean age
at arrhythmia symptom onset compared with those with AVNRT and have fewer associated cardiac abnormalities. Clinical presentation is quite similar
as well as their outcome after ablation. A correct diagnosis by standard
ECG is more frequent in AVNRT.
High prevalence of right ventricular involvement in endurance athletes with
ventricular arrhythmias
EUROPEAN HEART JOURNAL August
2003 | Volume 24, Issue 16 | Pages 1473-1480
Hein
Heidbüchel, Jan Hoogsteen, Robert Fagard, L. Vanhees, Hugo Ector, Rik Willems, Johan
Van Lierde
Complex ventricular arrhythmias do not
necessarily represent a benign finding in endurance athletes. An
electrophysiological study is indicated for risk evaluation, both by defining
inducibility and identifying the arrhythmogenic mechanism. Endurance athletes
with arrhythmias have a high prevalence of right ventricular structural and/or
arrhythmic involvement. Endurance sports seems to be related to the development
and/or progression of the underlying arrhythmogenic substrate.
Proportion and prognosis of healthy people with coved or saddle-back type ST
segment elevation in the right precordial leads during 10 years follow-up
EUROPEAN HEART JOURNAL August
2003 | Volume 24, Issue 16 | Pages 1488-1493
Masao
Sakabe,Akira Fujiki,Masanao Tani,Kunihiro Nishida,Koichi Mizumaki,Hiroshi
Inoue
The average proportion of healthy
subject who had coved or saddle-back type of ST elevation in the right
precordial leads without family history of sudden death was 1.22% and the risk
of fatal arrhythmias was low (1/393.5 subject-years).
INR Self-Management Permits Lower Anticoagulation Levels After Mechanical Heart
Valve Replacement
Circulation. 2003;108:II-75
H.
Koertke, MD; K. Minami, MD; D. Boethig, MD; Th. Breymann, MD; D. Seifert, MD;
O. Wagner; N. Atmacha, MD; A. Krian, MD; J. Ennker, MD; U. Taborski, MD; W.P.
Klövekorn, MD; R. Moosdorf, MD; W. Saggau, MD; R. Koerfer, MD
Early onset INR
self-management under oral anticoagulation after mechanical heart valve
replacement enables patients to keep within a lower and smaller INR target
range.
Effect of Modern Pacing Algorithms on Generator Longevity: A Predictive Analysis
Pacing and Clinical
Electrophysiology Volume 26 Issue 9 Page 1796 - September 2003
DAN
GELVAN, EUGENE CRYSTAL, BARBAROS DOKUMACI§, YUVAL GOLDSHMID and I. ELI
OVSYSHCHER
Two algorithms: Capture Management and
Search AV, have clinical relevance in the extension of PG longevity.
Radiofrequency Ablation of Probable Atrioventricular Nodal Reentrant Tachycardia
in Children with Documented Supraventricular Tachycardia Without Inducible
Tachycardia
Pacing and Clinical
Electrophysiology Volume 26 Issue 8 Page 1679 - August 2003
STEVEN
B. FISHBERGER
In selected patients, empiric slow
pathway modification may be offered as a potential cure in children with
recurrent paroxysmal SVT who are not inducible at electrophysiological study.
Elimination of slow pathway conduction may serve as a surrogate endpoint, though
is not necessary for long-term success.
Mapping and Ablation of Ventricular Fibrillation Associated With Long-QT and
Brugada Syndromes
Circulation. 2003;108:925
Michel
Haïssaguerre, MD; Fabrice Extramiana, MD; Mélèze Hocini, MD; Bruno Cauchemez,
MD; Pierre Jaïs, MD; Jose Angel Cabrera, MD; Geronimo Farre, MD; Antoine
Leenhardt, MD; Prashanthan Sanders, MBBS; Christophe Scavée, MD; Li-Fern Hsu,
MBBS; Rukshen Weerasooriya, MBBS; Dipen C. Shah, MD; Robert Frank, MD;
Philippe Maury, MD; Marc Delay, MD; Stéphane Garrigue, MD; Jacques Clémenty,
MD
Triggers from the
Purkinje arborization or the right ventricular outflow tract have a crucial role
in initiating ventricular fibrillation associated with the long-QT and Brugada
syndromes. These can be eliminated by focal radiofrequency ablation.
Prediction of sudden cardiac death after myocardial infarction in the
beta-blocking era
J Am Colleg Cardiol 20 August
2003, Volume 42, Issue 4 Pages 652-658
Heikki
V. Huikuri, Jari M. Tapanainen, Kai Lindgren, Pekka Raatikainen, Timo H.
Mäkikallio, K. E. Juhani Airaksinen and Robert J. Myerburg
The common arrhythmia risk variables,
particularly the autonomic and standard ECG markers, have limited predictive
power in identifying patients at risk of SCD after AMI in the beta-blocking era.
A Randomized Prospective Study of Single Coil Versus Dual Coil Defibrillation in
Patients with Ventricular Arrhythmias Undergoing Implantable Cardioverter
Defibrillator Therapy
Pacing and Clinical
Electrophysiology Volume 26 Issue 8 Page 1684 - August 2003
C. ALDO
RINALDI, RON D.B. SIMON, PETER GEELEN , SVEN REEK , ARTUR BASZKO, MARTIN KUEHL
, and JASWINDER S. GILL
No significant
advantage of a dual coil lead system over a single coil system in terms of lead
values and defibrillation thresholds.
Ablate and pace revisited: long term survival and predictors of permanent atrial
fibrillation
Heart 2003;89:1035-1038
A
Queiroga, H J Marshall, M Clune and M D Gammage
Ablate and pace is associated with a low
overall mortality. No predictors of permanent atrial fibrillation were
identified, but 48% of patients were still in sinus rhythm at 72 months. These results support the use of dual
chamber pacing for paroxysmal atrial fibrillation patients after ablate and
pace.
Short QT Syndrome A
Familial Cause of Sudden Death
Circulation. 2003;108:965
Fiorenzo
Gaita, MD; Carla Giustetto, MD; Francesca Bianchi, MD; Christian Wolpert, MD;
Rainer Schimpf, MD; Riccardo Riccardi, MD; Stefano Grossi, MD; Elena Richiardi,
MD; Martin Borggrefe, MD
The short QT syndrome is characterized
by familial sudden death, short refractory periods, and inducible ventricular
fibrillation. It is important to recognize this ECG pattern because it is
related to a high risk of sudden death in young, otherwise healthy subjects.
A randomized comparison of atrial and dual-chamber pacing in 177 consecutive
patients with sick sinus syndrome: Echocardiographic and clinical outcome
J Am Colleg Cardiol 20 August
2003, Volume 42, Issue 4 Pages 614-623
Jens C.
Nielsen, Lene Kristensen, Henning R. Andersen, Peter T. Mortensen, Ole L.
Pedersen and Anders K. Pedersen
During a mean follow-up of 2.9 ± 1.1
years, DDDR pacing causes increased LA
diameter, and DDDR pacing with a short atrioventricular delay also causes
decreased LVFS. No changes occur in LA or LV diameters or LVFS during AAIR
pacing. Atrial fibrillation is significantly less common during AAIR pacing.
Comparison of monophasic and biphasic shocks for transthoracic cardioversion of
atrial fibrillation
Heart 2003;89:1032-1034
M
Scholten, T Szili-Torok, P Klootwijk and L Jordaens
A protocol using monophasic waveform
shocks in a 200–360 J sequence has the same efficacy (90%) as a protocol using
rectilinear biphasic waveform shocks in a 120–200 J sequence.
A new pacemaker algorithm for the treatment of atrial fibrillation: Results of
the Atrial Dynamic Overdrive Pacing Trial (ADOPT)
J Am Colleg Cardiol 20 August
2003, Volume 42, Issue 4 Pages 627-633
Mark D.
Carlson, John Ip, John Messenger, Scott Beau, Steven Kalbfleisch, Pierre
Gervais, Douglas A. Cameron, Aurelio Duran, Jesus Val-Mejias, Judith Mackall,
Michael Gold and ADOPT Investigators
Overdrive atrial pacing with the AF
Suppression Algorithm decreased symptomatic AF burden significantly in patients
with sick sinus syndrome and AF.
The decrease in relative AF burden was substantial (25%), although the absolute
difference was small (2.50% control vs. 1.87% treatment).
Fish Consumption
Is Associated With Lower Heart Rates
Circulation. 2003;108:820
Jean
Dallongeville, MD, PhD; John Yarnell, MD, PhD; Pierre Ducimetière, PhD;
Dominique Arveiler, MD, PhD; Jean Ferrières, MD, MPH; Michèle Montaye, MD;
Gérald Luc, MD; Aluns Evans, MD, PhD; Annie Bingham, MSc; Bernadette Hass, MD;
Jean-Bernard Ruidavets, MD, PhD; Philippe Amouyel, MD, PhD
Fish consumption is associated with
decreased heart rate in men. Because heart rate is positively associated
with risk of sudden death, this association may explain, at least in part, the
lower risk of sudden death among fish consumers.
Effect of 7-Year Infancy-Onset Dietary Intervention on Serum Lipoproteins and
Lipoprotein Subclasses in Healthy Children in the Prospective, Randomized
Special Turku Coronary Risk Factor Intervention Project for Children (STRIP)
Study
Circulation. 2003;108:672
Tuuli
Kaitosaari, MD; Tapani Rönnemaa, MD, PhD; Olli Raitakari, MD, PhD; Sanna
Talvia, MSc; Katariina Kallio, MD; Iina Volanen, MD; Aila Leino, PhD; Eero
Jokinen, MD, PhD; Ilkka Välimäki, MD, MSc; Jorma Viikari, MD, PhD; Olli Simell,
MD, PhD
The 7-year intervention favorably
influenced not only the serum total and LDL cholesterol concentrations but also
the LDL particle size in boys.
Effects of initiating carvedilol in patients with severe chronic heart failure.
Results from the COPERNICUS study
JAMA 2003;289:712–8
H. Krum
, E.B. Roecker , P. Mohacsi and for the Carvedilol Prospective Randomized
Cumulative Survival (COPERNICUS) Study Group.
These data suggest that, in clinically euvolemic
patients, the relation of benefit to risk during early initiation of treatment
with carvedilol is similar to that seen during long-term therapy with the drug.
These findings should provide the reassurance needed to encourage the high
levels of use that are warranted by the results of long-term clinical trials.
The risks of β-blockade
have been significantly overestimated and the benefits underappreciated.
Benefits from carvedilol began to appear about 21 days after its initiation,
supporting both the importance of prompt initiation of therapy and the benefit
of even low doses of carvedilol (as seen in an earlier study of mild to moderate
heart failure). At this point, the
safety criteria utilized in COPERNICUS (clinical euvolemia, no intravenous
inotrope or vasodilator within the prior 4 days) remain a reasonable guideline
for initiation of therapy.
Complications of inappropriate use of spironolactone in heart failure: when an
old medicine spirals out of new guidelines
J Am Coll Cardiol 2003;41:211–4
B.
Bozkurt , I. Agoston and A.A. Knowlton
Complications of hyperkalemia,
hyponatremia and renal insufficiency were far more common in this study of
patients treated with spironolactone in clinical practice compared to patients
in the RALES trial. The RALES investigators reported
serious hyperkalemia (K≥6.0 mEq/L) in 2% of the patients treated with
spironolactone, and did not report less serious degrees of hyperkalemia.
Inhaled beta-2 adrenergic receptor agonists and primary cardiac arrest
Am J Med 2002;113:711–6
R.
Lemaitre , D.S. Siscovick and B.M. Psaty
A two-fold increase in the risk of cardiac
arrest. The increase risk of cardiac arrest is eliminated by the
concomitant use of inhaled steroids.
There are several possible
mechanisms by which inhaled β-agonists may increase the risk of cardiac arrest,
including: precipitation of ischemia in coronary artery disease; lowering of the
ventricular fibrillation threshold; triggering of ventricular tachycardia in
susceptible patients (e.g., prior myocardial infarction, idiopathic ventricular
tachycardia, long-QT syndrome).
Epinephrine unmasks latent mutation carriers with LQT1 form of congenital
long-QT syndrome
J Am Coll Cardiol
2002;41:633–42
W.
Shimizu , T. Noda and H. Takai
Although the sample sizes were
fairly small, the results suggest that an epinephrine challenge may be an
excellent screening tool for family members of a patient identified to have the
LQT1 form of LQTS. If these results are confirmed in larger studies, the
decision to institute prophylactic therapy for family members of probands could
be based simply on the response to epinephrine, rather than on the more
expensive and lengthy process of gene analysis.
Risk stratification in the
long-QT syndrome
N Engl J Med 2003;348:1866–74
S.G.
Priori , P.J. Schwartz and C. Napolitano
The risk of cardiac events in the LQTS is affected by the genotype and is the lowest in patients with LQTS1.
Asymptomatic patients at highest risk of a cardiac event consist of males or females with LQTS1 and a QTc
≥500 ms, males with LQTS2 and a
QTc ≥500 ms, females with LQTS2
(regardless of the QTc) and all
patients with LQTS3.
Complete heart block: determinants and clinical impact in patients with
hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction
therapy
J Am Colleg Cardiol 16 July 2003
(Vol 42, Issue 2) pages 296-300
Su Min
Chang MD, Sherif F. Nagueh MD, William H. Spencer, III MD, and Nasser M. Lakkis
MD
14% developed CHB after the procedure.
Multivariate logistic regression analysis showed that female gender, bolus injection of
ethanol,
injecting more than one septal artery, the presence of left bundle branch block, and first-degree AV
block on the baseline ECG are independent predictors
of CHB after NSRT. Patients with CHB
after NSRT derive similar clinical and hemodynamic benefit to patients who did
not require permanent pacing.
Maintenance of sinus
rhythm in patients with atrial fibrillation: An AFFIRM substudy of the first
antiarrhythmic drug
J Am Colleg Cardiol 2 July 2003 (Vol
42, Issue 1) 20-29
The AFFIRM
First Antiarrhythmic Drug Substudy Investigators
62% were
successfully treated with amiodarone, compared with 23% taking class I agents . In 256 patients randomized between amiodarone and sotalol, 60%
versus 38% were successfully treated, respectively. In 183
patients randomized between sotalol and
class I agents, 34% versus 23% were successfully treated, respectively.
Are lipid-lowering drugs
also antiarrhythmic drugs? an analysis of the antiarrhythmics versus implantable
defibrillators (AVID) trial
J Am Colleg Cardiol 2 July 2003 (Vol
42, Issue 1) pages 81-87
L. Brent
Mitchell MD, FACC, Judy L. Powell BSN, Anne M. Gillis MD, FACC, Victoria Kehl
PhC, Alfred P. Hallstrom PhD, and the AVID Investigators
Lipid-lowering therapy is associated
with reduction in the probability of VT/VF recurrence, suggesting that
part of the benefit of lipid-lowering therapy may be due to an antiarrhythmic
effect.
Significant effects of atrioventricular node ablation and pacemaker implantation
on left ventricular function and long-term survival in patients with atrial
fibrillation and left ventricular dysfunction
Am J Cardiol, 1 July 2003,
Volume 92, Issue 1 Pages 33-37
Cevher
Ozcan MD, Arshad Jahangir MD, Paul A. Friedman MD, Thomas M. Munger MD,
Douglas L. Packer MD, David O. Hodge MS, David L. Hayes MD, Bernard J. Gersh
MB, ChB, DPhil, Stephen C. Hammill MD and Win-Kuang Shen MD
Near normalization of
LVEF occurred in 29% of study patients, suggesting that AF-induced EF
reduction is reversible in many patients. Normal survival in patients with
reversible LV dysfunction highlights potential survival benefits of rate
control.
Mortality, Morbidity, and Complications in 3,344 Patients with Implantable
Cardioverter Defibrillators: Results From the German ICD Registry EURID
Pacing and Clinical
Electrophysiology 2003 Volume: 26 Number: 7 Page: 1511 -- 1518
RAINER
GRADAUS ; MICHAEL BLOCK ; JOHANNES BRACHMANN ; GÜNTER BREITHARDT ; HANS G.
HUBER ; WERNER JUNG ; WOLFGANG KRANIG ; RALPH U. MLETZKO ; WOLFGANG SCHOELS ;
KARLHEINZ SEIDL ; JOCHEN SENGES ; JÜRGEN SIEBELS ; GERHARD STEINBECK ;
CHRISTOPH STELLBRINK ; DIETRICH ANDRESEN
The 1-year survival rate was 93.5%. 39.8% had appropriate ICD therapies, 16.2% had inappropriate therapies.
When ICDs are
used in standard medical care, the 1-year survival rate is high, especially in
patients with NYHA Class I and preserved LVEF. However, nearly half of all
patients suffer from ICD intervention.
The
Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial
Pacing and Clinical
Electrophysiology 2003 Volume: 26 Number: 7 Page: 1566
Bruce L.
Wilkoff
For ICD patients, DDDR-70 pacing
exhibits no clinical advantage over VVI-40 pacing and may increase CHF and
mortality.
Holter Monitoring vs Tilt Testing in the Investigation of Suspected Vasovagal
Syncope
Pacing and Clinical
Electrophysiology 2003 Volume: 26 Number: 7 Page: 1523 -- 1527
ALAN
FITCHET ; MARLENE STIRLING ; GILL BURNETT ; GRAHAM K. GOODE ; CLIFFORD J.
GARRATT ; ADAM P. FITZPATRICK
Holter monitoring produces a low yield of clinically useful
information in the investigation of suspected vasovagal syncope. An HUT test should be considered the
primary investigation of choice in such patients.
The Second Vasovagal
Pacemaker Study (VPSII)
Pacing and Clinical
Electrophysiology 2003 Volume: 26 Number: 7 Page: 1565
Stuart
J. Connolly ; Robert Sheldon ; Kevin E. Thorpe ; Robin S. Roberts ; Kenneth A.
Ellenbogen ; Bruce L. Wilkoff ; Carlos Morillo ; Michael Gent
This
double blind randomized trial does not confirm the results of earlier smaller
unblinded randomized trials. Because of the weak evidence of efficacy of
pacemaker therapy and the risk of complications, pacemaker therapy should not be
recommended as first line therapy for patients with recurrent vasovagal syncope.
New Trial
Data on Prevention: Potassium and CV Risk in Hope
Pacing and Clinical
Electrophysiology 2003 Volume: 26 Number: 7 Page: 1565
Johannes
F. E. Mann ; Qi-Long Yi ; Peter Sleight ; Gilles R. Dagenais ; Jeff
Probstfield ; Hertzel C. Gerstein ; Eva M. Lonn ; Jackie Bosch ; Salim Yusuf
The combined primary outcome
(cardiovascular death, myocardial infarction, or stroke) increased with
hypokalemia (22.6% vs 15.5%, p 0.023, hazard ratio 1.44). Hyperkalemia conferred no hazard.
Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation
Among Patients With Normal Baseline QRS Duration in a Clinical Trial of
Pacemaker Therapy for Sinus Node Dysfunction
Circulation. 2003;107:2932
Michael
O. Sweeney, MD; Anne S. Hellkamp, MS; Kenneth A. Ellenbogen, MD; Arnold J.
Greenspon, MD; Roger A. Freedman, MD; Kerry L. Lee, PhD; Gervasio A. Lamas, MD
for the MOde Selection Trial (MOST) Investigators
Ventricular desynchronization imposed by
ventricular pacing even when AV synchrony is preserved increases the risk of HF
hospitalization and AF in SND with normal baseline QRSd.
Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left
Ventricular Dysfunction: Insight From the Studies Of Left Ventricular
Dysfunction (SOLVD) Trials
Circulation. 2003;107:2926
Emmanuelle Vermes, MD; Jean-Claude Tardif, MD; Martial G. Bourassa, MD;
Normand Racine, MD; Sylvie Levesque, MSc; Michel White, MD; Peter G. Guerra,
MD; Anique Ducharme, MD, MSc
AF during
the follow-up: 5.4% in the
enalapril group and 24% in
the placebo group (P<0.0001). Treatment with the ACEi enalapril
markedly reduces the risk of development of atrial fibrillation in patients with
left ventricular dysfunction.
The Seventh Report of the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report
JAMA. 2003;289:2560-2571
Aram V.
Chobanian, MD; George L. Bakris, MD; Henry R. Black, MD; William C. Cushman,
MD; Lee A. Green, MD, MPH; Joseph L. Izzo, Jr, MD; Daniel W. Jones, MD; Barry
J. Materson, MD, MBA; Suzanne Oparil, MD; Jackson T. Wright, Jr, MD, PhD;
Edward J. Roccella, PhD, MPH; and the National High Blood Pressure Education
Program Coordinating Committee
Individuals
with a systolic BP of 120 to 139 mm Hg or a diastolic BP of 80 to 89 mm Hg
should be considered as prehypertensive and require health-promoting lifestyle
modifications to prevent CVD;
Thiazide-type diuretics should be used in drug treatment for most patients with
uncomplicated hypertension, either alone or combined with drugs from other
classes.
Combined Cardiac Resynchronization and Implantable Cardioversion Defibrillation
in Advanced Chronic Heart Failure: The MIRACLE ICD Trial
JAMA. 2003;289:2685-2694
James B.
Young, MD; William T. Abraham, MD; Andrew L. Smith, MD; Angel R. Leon, MD; Randy
Lieberman, MD; Bruce Wilkoff, MD; Robert C. Canby, MD; John S. Schroeder, MD; L.
Bing Liem, DO; Shelley Hall, MD; Kevin Wheelan, MD; for The Multicenter InSync
ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators
Cardiac resynchronization
improved quality of life, functional status, and exercise capacity in patients
with moderate to severe HF, a wide QRS interval, and life-threatening
arrhythmias. These improvements occurred in the context of underlying
appropriate medical management without proarrhythmia or compromised ICD
function.
Estrogen Plus Progestin
and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal
Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial
JAMA. 2003;289:2651-2662
Sally A.
Shumaker, PhD; Claudine Legault, PhD; Stephen R. Rapp, PhD; Leon Thal, MD;
Robert B. Wallace, MD; Judith K. Ockene, PhD, MEd; Susan L. Hendrix, DO; Beverly
N. Jones III, MD; Annlouise R. Assaf, PhD; Rebecca D. Jackson, MD; Jane Morley
Kotchen, MD, MPH; Sylvia Wassertheil-Smoller, PhD; Jean Wactawski-Wende, PhD;
for the WHIMS Investigators
Estrogen plus progestin
therapy increased the risk for probable dementia in postmenopausal women aged 65
years or older. In addition, estrogen plus progestin therapy did not
prevent mild cognitive impairment in these women. These findings, coupled with
previously reported WHI data, support the conclusion that the risks of estrogen
plus progestin outweigh the benefits.
Prognostic Value of Ambulatory Blood-Pressure Recordings in Patients with
Treated Hypertension
N Engl J Med Volume
348:2407-2415 June 12, 2003 Number 24
Denis L.
Clement, M.D., Ph.D., Marc L. De Buyzere, B.Sc., Dirk A. De Bacquer, Ph.D.,
Peter W. de Leeuw, M.D., Ph.D., Daniel A. Duprez, M.D., Ph.D., Robert H.
Fagard, M.D., Ph.D., Peter J. Gheeraert, M.D., Luc H. Missault, M.D., Jacob J.
Braun, M.D., Roland O. Six, M.D., Patricia Van Der Niepen, M.D., Eoin O'Brien,
M.D., Ph.D., for the Office versus Ambulatory Pressure Study Investigators
In patients with treated hypertension, a
higher ambulatory systolic or diastolic blood pressure predicts cardiovascular
events even after adjustment for classic risk factors including office
measurements of blood pressure.
Amiodarone versus implantable cardioverter-defibrillator:randomized trial in
patients with nonischemicdilated cardiomyopathy and asymptomatic nonsustained
ventricular tachycardia—AMIOVIRT
J Am Colleg Cardiol 21 May
2003, Volume 41, Issue 10 Pages 1707-1712
S. Adam
Strickberger MD, FACC, John D. Hummel MD, FACC, Thomas G. Bartlett MD, FACC,
Howard I. Frumin MD, FACC, Claudio D. Schuger MD, FACC, Scott L. Beau MD, FACC
, Cynthia Bitar RN, Fred Morady MD, FACC and AMIOVIRT Investigators
Mortality and quality of life in
patients with NIDCM and NSVT treated with amiodarone or an ICD are not
statistically different. There is a trend towards a more beneficial cost
profile and improved arrhythmia-free survival with amiodarone therapy.
The Australian intervention randomized control of rate in atrial fibrillation
trial (AIRCRAFT)
J Am Colleg Cardiol 21 May
2003, Volume 41, Issue 10 Pages 1697-1702
Rukshen
Weerasooriya MBBS, BMedSc (hons), FRACP, Michael Davis MBBS, FRACP, Anne
Powell MBBS, PhD, FRACP, Tamas Szili-Torok MD, Chetan Shah MD, David Whalley
MBBS, PhD, FRACP, Logan Kanagaratnam MBBS, FRACP, William Heddle MBBS, FRACP,
James Leitch MBBS, FRACP, Ann Perks BSc, Louise Ferguson BSc and Max Bulsara
BSc (hons), MSc
AVJAP for patients with mild to
moderately symptomatic permanent AF did not worsen cardiac function during
long-term follow-up, and quality of life was improved.
Randomized trial of rate-control versus rhythm-control in persistent atrial
fibrillation: The Strategies of Treatment of Atrial Fibrillation (STAF) study
J Am Colleg Cardiol 21 May
2003, Volume 41, Issue 10 Pages 1690-1696
J.örg
Carlsson MD, FESC, Sinisa Miketic MD, J.ürgen Windeler MD, Alessandro Cuneo
MD, Sebastian Haun MD, Stefan Micus MD, Sabine Walter MD, Ulrich Tebbe MD,
FESC and STAF Investigators
No differences between the two treatment
strategies in all end points except hospitalizations. These data suggest
that there was no benefit in attempting rhythm-control in these patients with a
high risk of arrhythmia recurrence. It remains unclear whether the results in
the rhythm-control group would have been better if sinus rhythm had been
maintained in a higher proportion of patients, as all but one end point occurred
during AF.
Anterior-posterior vs. anterior-lateral electrode positions for external
cardioversion of atrial fibrillation: a randomized trial
Current J Review, March 2003,
Volume 12, Issue 2 Pages 87
P.
Kirchhoh , L. Eckardt and P. Loh
Transthoracic cardioversion is more
effective with anterior-posterior electrodes than with anterior-lateral
electrodes.
Perspective: With the
greater efficacy of biphasic shocks, it is likely that there will be a smaller
difference in the success rates of the two electrode configurations than when
monophasic shocks are used. Nevertheless, the electrode position does not affect
cost or morbidity, and based on the results of this study, it would seem
appropriate to use anterior-posterior electrodes whenever feasible in patients
undergoing cardioversion of AF.
Acute haemodynamic effects of testosterone in men with chronic heart failure
EUROPEAN HEART JOURNAL, May
2003 | Volume 24, Issue 10 | Pages 909-915
Peter J.
Pugh,T. Hugh Jones,Kevin S. Channer
Administration
of testosterone increases cardiac output acutely, apparently via reduction of
left ventricular afterload.
Pacemaker prevention therapies for the control of drug-refractory paroxysmal
atrial fibrillation
EUROPACE, April 2003 | Volume
5, Issue 2 | Pages 123-131
M.
Kale,D. H. Bennett
Atrial septal pacing resulted in a
marked improvement in AF burden and symptoms. Activation of specific prevention pacing
algorithms provided more continuous atrial pacing but had limited and
heterogeneous effects on AF burden.
The effect of atrial pacing therapies on atrial tachyarrhythmia burden and
frequency: Results of a randomized trial in patients with bradycardia and atrial
tachyarrhythmias
J Am Colleg Cardiol 4 June
2003, Volume 41, Issue 11 Pages 1926-1932
Michael
A. Lee MD, FACC, Richard Weachter MD, FACC, Scott Pollak MD, FACC, Mark S.
Kremers MD, FACC, Ajay M. Naik MD, Russell Silverman MD, FACC, Joann Tuzi RN,
Wayne Wang MS, Linda J. Johnson PhD, David E. Euler PhD and ATTEST
Investigators
This DDDRP pacemaker is safe, has accurate AT/AF detection, and
provides ATP with 54% efficacy as
defined by the device. The atrial prevention and termination therapies combined did not reduce AT/AF burden or
frequency in this patient population.
Implantation of Pacemakers and Implantable Cardioverter Defibrillators in Orally
Anticoagulated Patients
Pacing and Clinical
Electrophysiology Volume: 26 Number: 1 Supplement: 1 Page: 511 -- 514
AYMAN S.
AL-KHADRA
In experienced centers, patients requiring
treatment with warfarin may undergo implantation of pacemakers or defibrillators
with minimal risk despite continuation of anticoagulation.
Do airport metal detectors interfere with implantable pacemakers or
cardioverter-defibrillators?
J Am Colleg Cardiol, 4 June
2003, Volume 41, Issue 11 Pages 2054-2059
Christof
Kolb MD, Sebastian Schmieder MD, Günter Lehmann MD, Bernhard Zrenner MD,
Martin R. Karch MD, Andreas Plewan MD and Claus Schmitt MD
In vivo testing of PM and ICD systems
showed no EMI with a standard AMDG.
Clinical and
electrophysiological differences between patients with arrhythmogenic right
ventricular dysplasia and right ventricular outflow tract tachycardia
EUROPEAN HEART JOURNAL May 2003 |
Volume 24, Issue 9 | Pages 801-810
D. O'Donnell,D. Cox,J. Bourke,L. Mitchell,S.
Furniss
The tachycardia in the ARVD group displayed features
of re-entry in over 80%, but behaved with a triggered automatic basis in 97%
with RVOT. Ablation was complete or partial success in 12 (71%) patients with
ARVD and ventricular tachycardia (VT) recurred in eight (48%). In the RVOT
patients, ablation was a complete success in 97% with recurrent VT in 6%.
Long-term success in the RVOT patients was 95% in both patients with and without
MRI abnormalities.
The finding of abnormalities
on MRI does not have any bearing on arrhythmia mechanism, acute or long-term
success of RFA.
Is the Left Ventricular Lateral Wall the Best Lead Implantation Site for Cardiac
Resynchronization Therapy?
Pacing and Clinical
Electrophysiology Volume: 26 Number: 1 Supplement: 1 Page: 162 -- 168
MAURIZIO
GASPARINI ; MASSIMO MANTICA ; PAOLA GALIMBERTI ; MONICA BOCCIOLONE ; LUCA
GENOVESE ; MAURIZIO MANGIAVACCHI ; UGO LA MARCHESINA ; FRANCESCO FALETRA ;
CATHERINE KLERSY ; ROBERT COATES ; EDOARDO GRONDA
A significant improvement in cardiac
function and increase in exercise capacity were observed over time regardless of
the LV stimulation sites, either considered singly or grouped as lateral versus
septal sites.
Cardiac Resynchronization and Implantable Cardioverter Defibrillator Therapy:
Preliminary Results from the InSync Implantable Cardioverter Defibrillator
Italian Registry
Pacing and Clinical
Electrophysiology Volume: 26 Number: 1 Supplement: 1 Page: 148 -- 151
MAURIZIO
GASPARINI ; MAURIZIO LUNATI ; MARIO BOCCHIARDO ; MASSIMO MANTICA ; EDOARDO
GRONDA ; MARIA FRIGERIO ; DOMENICO CAPONI ; ANGELO CARBONI ; GIUSEPPE BORIANI ;
GABRIELE ZANOTTO ; PIER ANTONIO RAVAZZI ; ANTONIO CURNIS ; ANDREA PUGLISI ;
CATHERINE KLERSY ; ILARIA VICINI ; SERGIO CAVAGLIÀ
A rate of 12 episodes/100 person-months (95% CI 10-15) was measured in the
subgroup of patients with ACC/AHA class I indications, versus two episodes/100
person-months (95% CI 1-5) in the remainder of the population. AThe impact of ICD
combined with cardiac resynchronization therapy on arrhythmic profile,
mortality, and costs in this subgroup of patients need to be more precisely
studied, with a particular focus on the various types of underlying heart
disease.
Acute and long-term results of radiofrequency ablation of common atrial flutter
and the influence of the right atrial isthmus ablation on the occurrence of
atrial fibrillation
EUROPEAN HEART JOURNAL May 2003 |
Volume 24, Issue 10 | Pages 956-962
Sebastian Schmieder,Gjin Ndrepepa,Jun
Dong,Bernhard Zrenner,Jürgen Schreieck,Michael A.E. Schneider,Martin R.
Karch,Claus Schmitt
Acute success rate of 90% and a
long-term recurrence rate of 10%. Radiofrequency ablation of common AFL
results in a significant reduction in
the occurrence of atrial fibrillation.
Is the Outcome of Cardiac Resynchronization Therapy Related to the Underlying
Etiology?
Pacing and Clinical
Electrophysiology Volume: 26 Number: 1 Supplement: 1 Page: 175 -- 180
MAURIZIO GASPARINI ; MASSIMO MANTICA ; PAOLA
GALIMBERTI ; LUCA GENOVESE ; DANIELA PINI ; FRANCESCO FALETRA ; UGO LA
MARCHESINA ; MAURIZIO MANGIAVACCHI ; CATHERINE KLERSY ; EDOARDO GRONDA
Non-CAD patients
had a greater increase in LVEF and decrease in NYHA functional class than
patients with CAD.
Flecainide Test in Brugada Syndrome: A Reproducible but Risky Tool
Pacing and Clinical
Electrophysiology Volume: 26 Number: 1 Supplement: 1 Page: 338 -- 341
MAURIZIO
GASPARINI ; SILVIA G. PRIORI ; MASSIMO MANTICA ; CARLO NAPOLITANO ; PAOLA
GALIMBERTI ; CARLO CERIOTTI ; STEFANO SIMONINI
The reproducibility of the flecainide test
was 100%. In 4 (18%) of 22
patients major VAs were documented after the end of flecainide infusion.
Safety of a Single Successful Conversion of Ventricular Fibrillation Before the
Implantation of Cardioverter Defibrillators
Pacing and Clinical
Electrophysiology Volume: 26 Number: 1 Supplement: 1 Page: 483 -- 486
MICHAEL R.
GOLD ; DAVID BREITER ; ROBERT LEMAN ; ERIC J. RASHBA ; STEPHEN R. SHOROFSKY ;
STEPHEN J. HAHN
A first successful shock of
14 J may be a sufficient endpoint to allow the implantation of ICDs with the
Triad lead configuration, when programming all shocks to 31 J.
Relief of Drug Refractory Angina by Biventricular Pacing in Heart Failure
Pacing and Clinical
Electrophysiology Volume: 26 Number: 1 Supplement: 1 Page: 181 -- 184
MAURIZIO
GASPARINI ; MASSIMO MANTICA ; PAOLA GALIMBERTI ; CARLO CERIOTTI ; STEFANO
SIMONINI ; MAURIZIO MANGIAVACCHI ; EDOARDO GRONDA
The beneficial
effects of CRT on overall cardiac function may include a better control of angina in severely
symptomatic patients.
Transfemoral Pediatric Permanent Pacing: Long-term Results
Pacing and Clinical
Electrophysiology Volume: 26 Number: 1 Supplement: 1 Page: 487 -- 491
ROBERTO
COSTA ; MARTINO MARTINELLI FILHO ; WAGNER TETSUJI TAMAKI ; ELIZABETH SARTORIO
CREVELARI ; SILVANA D'ÓRIO NISHIOKA ; LUIZ FELIPE PINHO MOREIRA ; SÉRGIO ALMEIDA
OLIVEIRA
The durability and overall
long-term performance of transfemoral leads were excellent.
Determinants of Persistent Atrial Fibrillation in Patients with DDD Pacemaker
Implantation
Pacing and Clinical
Electrophysiology 2003 Volume: 26 Number: 3 Page: 719 -- 724
AHMET
DURAN DEMIR ; MUSTAFA SOYLU ; ÖZCAN ÖZDEMIR ; YÜCEL BALBAY ; SERKAN TOPALOGLU
; ALI S¸AS¸MAZ ; S¸ULE KORKMAZ
Persistent AF was documented in 21 (20.8%) patients.
Previous AF attacks, increased left
atrial dimension, P maximum value of 120 ms, and a PWD value of 40 ms were
associated with a significantly increased risk of persistent AF.
Mechanism of Decrease in the Atrial Potential After Implantation of a
Single-Lead VDD Pacemaker: Atrial Histological Changes After Implantation of a
VDD Pacemaker Lead in Dogs
Pacing and Clinical
Electrophysiology 2003 Volume: 26 Number: 3 Page: 685 -- 691
YUKEI
HIGASHI ; TOKUTADA SATO ; HISA SHIMOJIMA ; YOUICHI TAKEYAMA ; KO GOTO ;
TOSHIAKI MITSUYA ; FUMIAKI SAGAWA ; RYOKICHI ISHIKAWA ; YUMI ISHIKAWA
Macroscopically, the pacemaker lead was
covered with thrombus, and adhered to the atrial wall in 80% of animals. Inflammatory changes
developed in the atrial wall after implantation of the VDDPS, and this seemed to
be one of the mechanisms for the decrease of the atrial potential of the VDDPS.
Different responses to dobutamine in the presence of carvedilol or metoprolol in
patients with chronic heart failure
Heart 2003;89:621-624
E
Bollano, M Scharin Täng, Å Hjalmarson, F Waagstein and B Andersson
Patients with congestive
heart failure on a non-selective ß adrenoreceptor blocker or ß1 selective
blocker responded differently to the inotropic drug dobutamine: the ß1
blockade caused by metoprolol could be counteracted by dobutamine, whereas with
carvedilol a low dose of dobutamine increased cardiac output, and a higher dose
of dobutamine caused a pressor effect. These findings may be clinically relevant
when choosing an inotropic drug.
Quality-of-Life in Patients with Paroxysmal Atrial Fibrillation After Catheter
Ablation: Results of Long-Term Follow-Up
Pacing and Clinical
Electrophysiology 2003 Volume: 26 Number: 3 Page: 678 -- 684
ALI
ERDOGAN ; JOERG CARLSSON ; THOMAS NEUMANN ; ALEXANDER BERKOWITSCH ; JOERG
NEUZNER ; CHRISTIAN W. HAMM ; HEINZ F. PITSCHNER
Patients with PAF
experience a significant improvement in
QOL after a successful catheter ablation. In contrast, in patients with
recurrence of PAF the QOL showed improvement to a lesser extent and patients
experienced ongoing symptoms.
Comparison Between Biventricular Pacing and Single Site Pacing in Patients with
Poor Ventricular Function: A Hemodynamic Study
Pacing and Clinical
Electrophysiology 2003 Volume: 26 Number: 2 Page: 551 -- 558
C. VARMA
; P. O'CALLAGHAN ; E. ROWLAND ; N.G. MAHON ; W. MCKENNA ; A.J. CAMM ; S.J.D.
BRECKER
Pacing in patients with heart
failure and conduction delay can produce a hemodynamic benefit. There is
individual variation in the pacing site that leads to the greatest improvement.
In the group as a whole, biventricular and LV pacing produced only modest
improvements compared to RV pacing.
Elevations in Ventricular Pacing Threshold with the Use of the Y Adaptor:
Implications for Biventricular Pacing
Pacing and Clinical
Electrophysiology 2003 Volume: 26 Number: 3 Page: 747 -- 751
ROBERT
W. RHO ; VICKAS V. PATEL ; EDWARD P. GERSTENFELD ; SANJAY DIXIT ; JOSEPH W.
POKU ; HEATHER M. ROSS ; DAVID CALLANS ; DUSAN Z. KOCOVIC
During initial implantation, LV
thresholds obtained in a unipolar configuration prior to connecting to the “Y”
adaptor were significantly lower than thresholds obtained after connecting to
the “Y” adaptor. LV thresholds should be measured in an
LV tip to RV ring configuration or ideally in a combined tip (LV and RV) to
shared ring configuration in order to accurately assess LV thresholds.
Utility and Safety of Prolonged Temporary Transvenous Pacing Using an
Active-Fixation Lead: Comparison with a Conventional Lead
Pacing and Clinical Electrophysiology 2003 Volume: 26
Number: 5 Page: 1245 -- 1248
C.C. DE
COCK ; C.M.C. VAN CAMPEN ; J.A. IN'T VELD ; C.A. VISSER
Transvenous temporary pacing using active fixation is safe and is
associated with a low dislocation rate and a reduction in pacing related adverse
events.
Determination of Repetitive Slow Pathway Conduction for Evaluation of the
Efficacy of Radiofrequency Ablation in AVNRT
Pacing and Clinical
Electrophysiology 2003 Volume: 26 Number: 4 Page: 827 -- 835
PETER
LUKAC ; THOMAS A. BUCKINGHAM ; ROBERT HATALA ; LUBOS URBAN ; TIBOR MALACKY ;
PETER MARGITFALVI ; IGOR RIECANSKY
The presence of repetitive slow pathway
conduction identifies an unsuccessful application with a clinically meaningful
negative predictive value.
Effect of pacing mode on health-related quality of life in the Canadian Trial of
Physiologic Pacing
Am Heart J 2003;145:430-7
David
Newman, MD Ching Lau, MD Anthony S. L. Tang, MD Jane Irvine, PhD Miney
Paquette, MSc Kirsten Woodend, RN, MSc Paul Dorian, MD Michael Gent, DSc
Charles Kerr, MD Stuart J. Connolly, MD CTOPP Investigators
In this
largest randomized assessment of QOL in patients with pacemakers, with the
instruments used, there was no significant health-related QOL difference seen
between “physiologic” pacing and ventricular pacing.
Sustained ventricular arrhythmias and mortality among patients with acute
myocardial infarction: Results from the GUSTO-III trial
Am Heart J 2003;145:515-21
Sana M.
Al-Khatib, MD, MHS Amanda L. Stebbins, MS Robert M. Califf, MD Kerry L. Lee,
PhD Christopher B. Granger, MD Harvey D. White, DSc Paul W. Armstrong, MD Eric
J. Topol, MD E. Magnus Ohman, MD
Despite thrombolysis,
inhospital ventricular arrhythmias are associated with higher 30-day and 1-year
mortality rates after acute myocardial infarction, particularly when occurring
later during the initial hospitalization. Better therapies are needed to
improve outcomes of these arrhythmias.
Temporary Atrial Epicardial Pacing as Prophylaxis Against Atrial Fibrillation
after Heart Surgery: A Meta-Analysis
Journal of Cardiovascular
Electrophysiology 2003 Volume: 14 Number: 2 Page: 127 -- 132
EMILE G. DAOUD ; RICK SNOW ; JOHN D. HUMMEL ; STEVEN J. KALBFLEISCH ;
RAUL WEISS ; RALPH AUGOSTINI
Biatrial overdrive and fixed high-rate pacing and right
atrial fixed high-rate pacing reduced the risk of new-onset AF after open heart
surgery, and the relative risk reduction is approximately 2.5-fold. These
results imply that various pacing algorithms are useful as a nonpharmacologic
method to prevent postoperative AF.
Heart Rate Versus Heart Rate Variability in Risk Prediction after Myocardial
Infarction
Journal of
Cardiovascular Electrophysiology 2003 Volume: 14 Number: 2 Page: 168 -- 173
STEEN Z. ABILDSTROM ; BERIT T. JENSEN ; ERIK AGNER ; CHRISTIAN TORP-PEDERSEN
; OLE NYVAD ; KRISTIAN WACHTELL ; MICHAEL M. OTTESEN ; JØRGEN K. KANTERS
The prognostic information of HRV is contained completely in
heart rate, which carries prognostic information further than that of HRV. This
result was independent of beta-blocker treatment.
Novel Brugada SCN5A Mutation Leading to ST Segment Elevation in the Inferior or
the Right Precordial Leads
Journal of Cardiovascular Electrophysiology 2003
Volume: 14 Number: 2 Page: 200 -- 203
FRANCK
POTET ; PHILIPPE MABO ; GUILLAUME LE COQ ; VINCENT PROBST ; JEAN-JACQUES
SCHOTT ; FABRICE AIRAUD ; GILLES GUIHARD ; JEAN-CLAUDE DAUBERT ; DENIS ESCANDE
; HERVÉ LE MAREC
We provide genetic demonstration that Brugada ECG anomalies related to a
unique SCN5A mutation can be observed either in the inferior or the right
precordial leads.
What characterizes episodes of atrial fibrillation requiring cardioversion?
Experience from patients with an implantable atrial cardioverter
Am Heart J 2003;145:670-5
Viveka Frykman, MD Gregory M. Ayers, MD, PhD, FACC Börje Darpö, MD, PhD
Mårten Rosenqvist, MD, PhD
Episodes of atrial fibrillation that cause the patient to
seek cardioversion are characterized by a high initial ventricular rate and a
longer duration than those that go untreated.
Electrical Resynchronization: A Novel Therapy for the Failing Right Ventricle
Circulation. 2003;107:2287
Anne M. Dubin, MD; Jeffrey A. Feinstein, MD; V. Mohan Reddy, MD; Frank
L. Hanley, MD; George F. Van Hare, MD; David N. Rosenthal, MD
Atrioventricular
pacing in patients with RBBB and RV dysfunction augments RV and systemic
performance. RV resynchronization is a promising novel therapy for
patients with RV failure.
Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe,
Chronic Ischemic Heart Failure
Circulation. 2003;107:2294
Emerson C. Perin, MD, PhD; Hans F.R. Dohmann, MD; Radovan Borojevic,
PhD; Suzana A. Silva, MD; Andre L.S. Sousa, MD; Claudio T. Mesquita, MD, PhD;
Maria I.D. Rossi, PhD; Antonio C. Carvalho, MD, PhD; Helio S. Dutra, PhD; Hans
J.F. Dohmann, MD, PhD; Guilherme V. Silva, MD; Luciano Belém, MD; Ricardo
Vivacqua, MD; Fernando O.D. Rangel, MD; Roberto Esporcatte, MD; Yong J. Geng,
MD, PhD; William K. Vaughn, PhD; Joao A.R. Assad, MD; Evandro T. Mesquita, MD,
PhD; James T. Willerson, MD
The present study demonstrates the relative safety of intramyocardial injections of bone marrow–derived stem cells in humans with
severe heart failure and the potential for improving myocardial blood flow with
associated enhancement of regional and global left ventricular function.
Effects of high-dose furosemide and small-volume hypertonic saline solution
infusion in comparison with a high dose of furosemide as bolus in refractory
congestive heart failure: Long-term effects
Am Heart J 2003;145:459-66
Giuseppe
Licata, MD Pietro Di Pasquale, MD Gaspare Parrinello, MD Antonietta Cardinale,
MD Angela Scandurra, MD Giuseppe Follone, MD Christiano Argano, MD Antonino
Tuttolomondo, MD Salvatore Paterna, MD
This treatment is effective and well
tolerated, improves the quality of life through the relief of signs and symptoms
of congestion, and may delay more aggressive treatments. The effects were also beneficial in a
long period for mortality reduction (55% vs 13% survival rate) and for clinical
improvement.
Cardiac Resynchronization
and Death From Progressive Heart Failure. A Meta-analysis of Randomized
Controlled Trials
JAMA. 2003;289:730-740
David J.
Bradley, MD, PhD; Elizabeth A. Bradley, MD; Kenneth L. Baughman, MD; Ronald D.
Berger, MD, PhD; Hugh Calkins, MD; Steven N. Goodman, MD, PhD; David A. Kass,
MD; Neil R. Powe, MD, MPH, MBA
Cardiac resynchronization
reduces mortality from progressive heart failure in patients with symptomatic
left ventricular dysfunction. This finding suggests that cardiac
resynchronization may have a substantial impact on the most common mechanism of
death among patients with advanced heart failure. Cardiac resynchronization also reduces
heart failure hospitalization and shows a trend toward reducing all-cause
mortality.
Two-decade-long trends (1975-1997) in the incidence, hospitalization, and
long-term death rates associated with complete heart block complicating acute
myocardial infarction: A community-wide perspective
Am Heart J 2003;145:500-7
Frederick A. Spencer, MD Samer Jabbour, MD Darleen Lessard, MS Jorge Yarzebski,
MD, MPH Shmuel Ravid, MD Virginia Zaleskas, MD Michael Hyder, MD Joel M. Gore,
MD, FACC Robert J. Goldberg, PhD
Overall, CHB developed in 5.0% of
patients with AMI. The incidence of CHB complicating AMI has declined with time. The
hospital prognosis of patients in whom CHB developed has improved, but these
patients remain at an increased risk of hospital mortality. The long-term prognosis of patients with
inferior MI and CHB is similar to that of patients in whom CHB did not develop.
Patients with anterior MI and CHB may be at an increased risk of long-term
mortality.
Implantable Cardioverter Defibrillator in High-Risk Long QT Syndrome Patients
Journal of Cardiovascular Electrophysiology 2003
Volume: 14 Number: 4 Page: 337 -- 341
WOJCIECH ZAREBA ; ARTHUR J. MOSS ; JAMES P. DAUBERT ; W. JACKSON HALL ;
JENNIFER L. ROBINSON ; MARK ANDREWS
There was 1
(1.3%) death in 73 ICD patients followed an average of 3 years, whereas there
were 26 deaths (16%) in non-ICD patients during mean 8-year follow-up (P
= 0.07 from log rank test from Kaplan-Meier curves).
ICDs provide an important therapeutic option to prevent sudden arrhythmic death
in high-risk LQTS patients.
Effectiveness of implantable defibrillators for preventing arrhythmic events and
death: A meta-analysis
J Am Colleg Cardiol
7 May 2003, Volume 41, Issue 9 Pages 1573-1582
Douglas S. Lee MD, FRCPC, Lawrence D. Green MD, Peter P. Liu MD, FRCPC,
Paul Dorian MD, MSc, FRCPC, David M. Newman MD, FACC, F. Curry Grant MD, MSc,
FRCPC, Jack V. Tu MD, PhD, FRCPC and David A. Alter MD, PhD, FRCPC
The primary and
secondary prevention trials showed a significant benefit of the ICD with respect
to arrhythmic death, with relative risks (RR) of 0.34 and 0.50, respectively
(both p < 0.001). Although the ICD decreases the risk of arrhythmic
death, its impact on all-cause mortality is related to the underlying risk of
arrhythmia-related death relative to competing causes. Given the cost of the
device strategy, policies of targeted intervention based on the future risk of
arrhythmia are warranted.
Natural History of Brugada Syndrome: The Prognostic Value of Programmed
Electrical Stimulation of the Heart
Journal of Cardiovascular Electrophysiology 2003
Volume: 14 Number: 5 Page: 455 -- 457
Pedro
Brugada ; Ramon Brugada ; Lluis Mont ; Maximo Rivero ; Peter Geelen ; Josep
Brugada
Symptomatic patients were more frequently inducible [126/180 (70%)] than
asymptomatic individuals [91/263 (34%); P = 0.0001 ].
Males
were more frequently inducible than females (54% vs 32%, P < 0.0001 ).
Inducible individuals had a longer HV interval than noninducible patients
( 50 ± 12 msec vs 46 ± 10 msec, P < 0.002 ). Inducibility of sustained ventricular arrhythmias during
programmed ventricular stimulation of the heart is a good predictor of outcome
in Brugada syndrome.
Clinical and Electrophysiologic Predictors of Ventricular Tachyarrhythmia
Recurrence in Patients with Implantable Cardioverter Defibrillators
Journal of Cardiovascular Electrophysiology 2003
Volume: 14 Number: 5 Page: 492 -- 498
Anne M. Gillis ; Robert S. Sheldon
; D. George Wyse ; Henry J. Duff ; Margaret R. Cassidy ; L. Brent Mitchell
Inducibility of sustained VT/VF post-ICD
implant (P < 0.001) and sustained VT as the presenting arrhythmia (P = 0.02)
were independent predictors of spontaneous VT/VF recurrence.
Calcium antagonists reduce cardiovascular complications after cardiac surgery: A
meta-analysis
J Am Colleg Cardiol
7 May 2003, Volume 41, Issue 9 Pages 1496-150
Duminda N. Wijeysundera MD, W. Scott Beattie MD, PhD, Vivek Rao MD, PhD
and Jacek Karski MD
Use of CAs during cardiac surgery
significantly reduced rates of MI, ischemia, and SVT. Further
study using large RCTs is justified.
A meta-analysis of randomized controlled trials comparing coronary artery bypass
graft with percutaneous transluminal coronary angioplasty: one- to eight-year
outcomes
J Am Colleg Cardiol
16 April 2003, Volume 41, Issue 8 Pages
1293-1304
Stuart N. Hoffman DO, John A. TenBrook Jr MD, Michael P. Wolf MD,
Stephen G. Pauker MD, FACC, Deeb N. Salem MD, FACC and John B. Wong MD
When compared with PTCA, CABG is
associated with a lower five-year mortality, less angina, and fewer
revascularization procedures. For patients with multivessel disease, CABG
provided a survival advantage at five to eight years, and for diabetics, a
survival advantage at four years. The
addition of stents reduced the need for repeat revascularization by about half.
Efficacy and tolerability of eplerenone and losartan in hypertensive black and
white patients
J Am Colleg Cardiol
2 April 2003, Volume 41, Issue 7 Pages
1148-1155
John M. Flack MD, MPH, Suzanne Oparil MD. Howard Pratt MD, Barbara
Roniker MD, Susan Garthwaite PhD, Jay H. Kleiman MD, MPA, Yonghong Yang PhD,
Scott L. Krause BSN, Diane Workman PhD and Elijah Saunders MD
The antihypertensive effect of eplerenone was
equal in black and white patients and was superior to losartan in black patients.
Nitroprusside in Critically Ill Patients with Left Ventricular Dysfunction and
Aortic Stenosis
New Engl J Med Volume
348:1756-1763 May 1, 2003 Number 18
Umesh N. Khot, M.D., Gian M. Novaro, M.D., Zoran B. Popovi, M.D., Roger
M. Mills, M.D., James D. Thomas, M.D., E. Murat Tuzcu, M.D., Donald Hammer,
M.D., Steven E. Nissen, M.D., and Gary S. Francis, M.D.
Nitroprusside
rapidly and markedly improves cardiac function in patients with decompensated
heart failure due to severe left ventricular systolic dysfunction and severe
aortic stenosis. It provides a safe and effective bridge to aortic-valve
replacement or oral vasodilator therapy in these critically ill patients.
Uric Acid and Survival in Chronic Heart Failure. Validation and Application in
Metabolic, Functional, and Hemodynamic Staging
Circulation. 2003;107:1991
Stefan D. Anker, MD, PhD; Wolfram Doehner, MD; Mathias Rauchhaus, MD;
Rakesh Sharma, MRCP; Darrel Francis, MRCP; Christoph Knosalla, MD;
Constantinos H. Davos, MD, PhD; Mariantonietta Cicoira, MD; Waqar Shamim, MRCP;
Michel Kemp, MD; Robert Segal, MD; Karl Josef Osterziel, MD; Francisco Leyva,
MD; Roland Hetzer, MD; Piotr Ponikowski, MD; Andrew J.S. Coats, DM
High serum UA levels are a strong, independent marker of
impaired prognosis in patients with moderate to severe CHF. The relationship
between serum UA and survival in CHF is graded.
An
Association between Atherosclerosis and Venous Thrombosis
New Engl J Med Volume
348:1435-1441 April 10, 2003 Number 15
Paolo Prandoni, M.D., Ph.D., Franca Bilora, M.D., Antonio Marchiori,
M.D., Enrico Bernardi, M.D., Francesco Petrobelli, M.D., Anthonie W.A. Lensing,
M.D., Ph.D., Martin H. Prins, M.D., Ph.D., and Antonio Girolami, M.D.
The odds ratios for carotid plaques in
patients with spontaneous thrombosis, as compared with patients with secondary
thrombosis and with controls, were 2.3 (95 percent confidence interval, 1.4 to
3.7) and 1.8 (95 percent confidence interval, 1.1 to 2.9), respectively. There
is an association between atherosclerotic disease and spontaneous venous
thrombosis. Atherosclerosis may induce venous thrombosis, or the two conditions
may share common risk factors.
Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and
Stroke. Report of the Atrial Diagnostics Ancillary Study of the MOde Selection
Trial (MOST)
Circulation. 2003;107:1614
Taya V. Glotzer, MD; Anne S. Hellkamp, MS; John Zimmerman, MD; Michael
O. Sweeney, MD; Raymond Yee, MD; Roger Marinchak, MD; James Cook, MD;
Alexander Paraschos, MD; John Love, MD; Glauco Radoslovich, MD; Kerry L. Lee,
PhD; Gervasio A. Lamas, MD for the MOST Investigators
AHRE detected by pacemakers in patients with SND identify
patients that are more than twice as
likely to die or have a stroke, and 6 times as likely to develop atrial
fibrillation as similar patients without AHRE.
Prevention of Heart Failure in Patients in the Heart Outcomes Prevention
Evaluation (HOPE) Study
Circulation. 2003;107:1284
J. Malcolm O. Arnold, MD; Salim Yusuf, MD; James Young, MD; James
Mathew, MD; David Johnstone, MD; Alvaro Avezum, MD; Eva Lonn, MD; Janice
Pogue, MSc; Jackie Bosch, MSc on behalf of the HOPE Investigators
Ramipril reduced new-onset heart failure rate from 11.5% to 9.0%.
Enalapril Reduces the Incidence of Diabetes in Patients With Chronic Heart
Failure. Insight From the Studies Of Left Ventricular Dysfunction (SOLVD)
Circulation. 2003;107:1291
Emmanuelle Vermes, MD; Anique Ducharme, MD, MSc; Martial G. Bourassa, MD;
Myriam Lessard; Michel White, MD; Jean-Claude Tardif, MD
Enalapril remained the most powerful
predictor for risk reduction of developing diabetes (hazard ratio, 0.22);
Sotalol testing unmasks
altered repolarization in patients with suspected acquired long-QT-syndrome—a
case-control pilot study using i.v. sotalol
EUROPEAN HEART JOURNAL April
2003 | Volume 24, Issue 7 | Pages 649-657
Stefan
Kääb,Martin Hinterseer,Michael Näbauer,Gerhard Steinbeck
Controlled exposure to
sotalol successfully identifies patients with normal QTc intervals but altered
myocardial repolarization. This may be useful for clarifying diagnosis and
pathogenesis of acquired Long-QT-Syndrome.
Long QTc
predicts future cardiac death in stroke survivors
Heart 2003;89:377-381
K Y K
Wong1, R S Mac Walter2, D Douglas2, H W Fraser2, S A Ogston3 and A D
Struthers1
Stroke survivors
with a prolonged QTc in lead V6 are still at a high risk of cardiac death
and may need more intensive investigations and treatments than are currently
routine practice.
Head-up tilt test with clomipramine challenge in vasovagal syndrome—a new tilt
testing protocol
EUROPEAN HEART JOURNAL April 2003 | Volume 24, Issue 7 |
Pages 658-663
G.N.
Theodorakis,E.G. Livanis,D. Leftheriotis,P. Flevari,M. Markianos,D.Th.
Kremastinos
The predictive accuracy of Clom-HUT increased compared to Conventional HUT from 58 to
86%, respectively.
The results indicate an increased responsiveness of central serotonergic
neural system in subjects with vasovagal syndrome, the activation of which leads
to sympathetic withdrawal. The use of clomipramine infusion during tilt test
seems to improve considerably its diagnostic value.
Hypertrophic cardiomyopathy in a large community-based population: clinical
outcome and identification of risk factors for sudden cardiac death and clinical
deterioration
J AM Coll Cardiol 19 March 2003, Volume 41, Issue 6 Pages
987-993
Marcel J.M. Kofflard MD, Folkert J. Ten Cate MD, FACC, Chris van der Lee
MD and Ron T. van Domburg MSc
Hypertrophic
cardiomyopathy is a benign disease in an unselected population with a low
incidence of cardiac death. Syncope was associated with a higher
incidence of SCD and patients with a significant LVOT obstruction were more
susceptible to clinical deterioration.
Development and validation of a simple risk score to predict the need for
permanent pacing after cardiac valve surgery
J AM Coll Cardiol 5 March 2003,
Volume 41, Issue 5 Pages 795-801
Bruce A. Koplan MD, William G. Stevenson MD, FACC, Laurence M. Epstein
MD, FACC, Sary F. Aranki MD and William H. Maisel MD, MPH
Preoperative right
bundle branch block (odds ratio [OR], 3.6; 95% confidence interval [CI],
2.3 to 5.7) and multivalve surgery that
included the tricuspid valve (OR, 3.7; 95% CI, 2.3 to 6.1) were the
strongest independent predictors of PPM, while multivalve surgery that did not
include the tricuspid valve (OR, 2.1; 95% CI, 1.3 to 3.3), preoperative left
bundle branch block (OR, 2.0; 95% CI, 1.3 to 2.9), preoperative PR interval >200
ms (OR, 1.9; 95% CI, 1.3 to 3.0), prior valve surgery (OR, 1.8, 95% CI, 1.2 to
2.7), and age >70 years (OR, 1.4; 95% CI, 1.04 to 2.0) also predicted PPM. A
risk score from 0 to 6 identified patients in the VG with incidences of PPM of
1.9%, 5.2%, 8.7%, 11.5%, 21%, 36%, and 50%, respectively.
Oral Health and Peripheral
Arterial Disease
Circulation. 2003;107:1152
Hsin-Chia Hung, DDS, DrPH; Walter Willett, MD, DrPH; Anwar Merchant, DMD,
DrPH; Bernard A. Rosner, PhD; Alberto Ascherio, MD, DrPH; Kaumudi J. Joshipura,
ScD
Incident tooth loss was significantly associated with PAD, especially among men
with periodontal diseases. The results support a potential oral
infection–inflammation pathway.
Dual-chamber pacing or ventricular backup pacing in patients with an implantable
defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
JAMA 2002 Dec 25;288(24):3115-23
Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H,
Kutalek SP, Sharma A; Dual Chamber and VVI Implantable Defibrillator Trial
Investigators.
For patients with standard indications
for ICD therapy, no indication for cardiac pacing, and an LVEF of 40% or less,
dual-chamber pacing offers no clinical advantage over ventricular backup pacing
and may be detrimental by increasing the combined end point of death or
hospitalization for heart failure.
Fibrinolysis of mechanical prosthetic valve thrombosis: A single-center study of
127 cases
J Am Coll Cardiol
19 February 2003, Volume 41, Issue 4
Pages 653-658
Raymond
Roudaut MD, FESC, S.téphane Lafitte MD, PhD, Marie-Françoise Roudaut MD,
Carine Courtault MD, Jean-Marie Perron MD, Catherine Jas MD, Xavier Pillois
PhD, Pierre Coste MD and Anthony DeMaria MD, FACC
FT is effective in most cases of PHVT,
regardless of prosthesis or site involved. However, embolism, hemorrhage, and death
were not uncommon after lytic therapy of left-sided PHVT, limiting its
application to patients at high risk with alternative treatment.
Frequent Ventricular Ectopy after Exercise as a Predictor of Death
N Engl J Med
Volume 348:781-790 February 27, 2003 Number 9
Joseph P. Frolkis, M.D., Ph.D., Claire E. Pothier, M.S., Eugene H.
Blackstone, M.D., and Michael S. Lauer, M.D.
Frequent ventricular
ectopy during recovery after exercise is a better predictor of an increased risk
of death than ventricular ectopy occurring only during exercise.
Asymptomatic or "Silent" Atrial Fibrillation, Frequency in Untreated Patients
and Patients Receiving Azimilide
Circulation. 2003;107:1141
Richard L. Page, MD; Thomas W. Tilsch, BS; Stuart J. Connolly, MD;
Daniel J. Schnell, PhD; Stephen R. Marcello, MD; William E. Wilkinson, PhD;
Edward L.C. Pritchett, MD for the Azimilide Supraventricular Arrhythmia
Program (ASAP) Investigators
Asymptomatic atrial
fibrillation is common in untreated patients with a history of symptomatic
atrial fibrillation (and is likely underestimated by this analysis).
Asymptomatic atrial fibrillation was
recorded in 50 (17%) within 6 months. Azimilide may reduce the occurrence of this silent arrhythmia.
A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and
Diuretics for Hypertension in the Elderly
N Engl J Med
Volume 348:583-592 February 13, 2003 Number 7
Lindon M.H. Wing, M.B., B.S., Christopher M. Reid, Ph.D., Philip Ryan,
M.B., B.S., Lawrence J. Beilin, M.D., Mark A. Brown, M.B., B.S., M.D., Garry
L.R. Jennings, M.D., Colin I. Johnston, M.B., B.S., John J. McNeil, M.B.,
B.S., Graham J. Macdonald, M.D., John E. Marley, M.D., M.B., Ch.B., Trefor O.
Morgan, M.B., B.S., Malcolm J. West, M.B., B.S., for the Second Australian
National Blood Pressure Study Group
Initiation of
antihypertensive treatment involving ACE inhibitors in older subjects,
particularly men, appears to lead to better outcomes than treatment with
diuretic agents, despite similar reductions of blood pressure.
Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol
for reduction of hospital length of stay after heart surgery: The -Blocker
Length Of Stay (BLOS) study
Am Heart J 2003;145:226-32
Prophylactic
metoprolol reduces the risk of AF after heart surgery. It does not reduce
hospital length of stay. Although it is cost effective for the reduction of AF,
it did not reduce the overall cost of care.
Usefulness of invasive electrophysiologic testing to stratify the risk of
arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern:
Results from a large prospective long-term follow-up study
JACC 15 January 2003, Volume 41, Issue 2 Pages 239-244
Carlo Pappone MD, PhD, Vincenzo Santinelli MD, Salvatore Rosanio MD,
PhD, Gabriele Vicedomini MD, Stefano Nardi MD, Alessia Pappone MD, Valter
Tortoriello MD, Francesco Manguso MD, PhD, Patrizio Mazzone MD, Simone
Gulletta MD, Giuseppe Oreto MD and Ottavio Alfieri MD
In asymptomatic WPW
subjects, EPT may be a valuable tool to stratify the risk of symptomatic and
fatal arrhythmic events.
Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in
elderly patients with atrial fibrillation and prior myocardial infarction
JACC 15 January 2003, Volume 41, Issue 2 Pages 249-254
Vidal Essebag MD, MSc, FRCP, Tom Hadjis MD, MS, FRCP, Robert W. Platt
PhD and Louise Pilote MD, MPH, PhD
The use of amiodarone in elderly
patients with AF and a previous MI increases the risk of bradyarrhythmia
requiring a permanent pacemaker. Greater risk in women. Digoxin was
the only other medication associated with an increased risk of pacemaker
insertion.
Short-Term Heart Rate Variability Strongly Predicts Sudden Cardiac Death in
Chronic Heart Failure Patients
Circulation. 2003;107:565
Maria
Teresa La Rovere, MD; Gian Domenico Pinna, MS; Roberto Maestri, MS; Andrea
Mortara, MD; Soccorso Capomolla, MD; Oreste Febo, MD; Roberto Ferrari, MD;
Mariella Franchini, MD; Marco Gnemmi, MD; Cristina Opasich, MD; Pier Giorgio
Riccardi, MD; Egidio Traversi, MD; Franco Cobelli, MD
Reduced short-term
LFP during controlled breathing is a powerful predictor of sudden death in
patients with CHF that is independent of many other variables. These
results refine the identification of patients who may benefit from prophylactic
implantation of a cardiac defibrillator.
Atrial fibrillation: relation between clinical risk factors and transoesophageal
echocardiographic risk factors for thromboembolism
Heart 2003; 89: 165-168
S Illien, S Maroto-Järvinen, G von der Recke, C Hammerstingl, H Schmidt,
S Kuntz-Hehner, B Lüderitz and H Omran
There is a close relation between clinical risk factors and TOE
markers of a thrombogenic milieu. In addition, TOE examination allows for the
identification of patients with a thrombogenic milieu without clinical risk factors.
Mitral annular calcification: a marker of severe coronary artery disease in
patients under 65 years old
Heart 2003; 89: 161-164
S Atar,
D S Jeon, H Luo and R J Siegel
In patients aged 65 years, mitral annular calcification is
associated with an increased prevalence of severe obstructive coronary artery
disease. It may serve as a useful echocardiographic marker for the presence of
obstructive coronary artery disease, especially when associated with anginal
symptoms.
Prognostic value of QT interval and QT dispersion in patients with left
ventricular systolic dysfunction: Results from a cohort of 2265 patients with an
ejection fraction of 40%
Am Heart J 2003;145:132-8
Sriram
Padmanabhan, MD, Helme Silvet,
MD, Jatin Amin, MD,
Ramdas G. Pai, MD, Loma Linda
Both QTc
prolongation and increased QTd are associated with higher mortality rate in
patients with moderate and severe LV dysfunction.
Mechanism of syncope in patients with positive adenosine triphosphate tests
J Am Coll Cardiol
January 2003, Volume 41, Issue 1 Pages 93-98
Paolo Donateo MD, Michele Brignole MD, Carlo Menozzi MD, Nicola Bottoni
MD, Paolo Alboni MD, Maurizio Dinelli MD, Attilio Del Rosso MD, Francesco
Croci MD, Daniele Oddone MD, Alberto Solano MD and Enrico Puggioni MD
In patients with
adenosine-sensitive syncope, the mechanism of syncope is heterogeneous, although
bradycardia is the most frequent finding. Adenosine triphosphate–induced AV block
predicts AV block as the mechanism of spontaneous syncope in only a few
tilt-negative patients.
Current Use of Unopposed Estrogen and Estrogen Plus Progestin and the Risk of
Acute Myocardial Infarction Among Women With Diabetes
Circulation. 2003;107:43
Assiamira Ferrara, MD, PhD; Charles P. Quesenberry, PhD; Andrew J.
Karter, PhD; Catherine W. Njoroge, MS; Alice S. Jacobson, MS; Joseph V. Selby,
MD, MPH
In women without a
recent MI, use of estrogen plus progestin was associated with decreased risk of
MI. However, HRT was associated
with increased risk of MI in women with history of a recent MI.
|